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CHAPTER I: INTRODUCTION
Free ionic calcium (Ca2+) plays an essential role as a second messenger that
initiates muscle contraction in the heart (Bers, 2002). In the event that intracellular Ca2+
regulation is compromised, both the contractility and electrical excitability of the heart
can be altered (Rubart & Zipes, 2005;Morgan, 1991). As a consequence, heart function
may not be able to maintain the necessary cardiac output to meet the metabolic
demand of the body.
During a cardiac cycle, the movement of Ca2+ is regulated by proteins that
function as channels and pumps, which localize on the sarcolemma and the
sarcoplasmic reticulum (SR) (Bers, 2002). The SR is a specialized organelle in muscle that
acts as a Ca2+ store for the purpose of generating a robust rise in cytosolic Ca2+
concentration ([Ca2+]i) during systole. This cytosolic Ca2+ release event is known as a
global (non-localized) Ca2+ transient. During diastole, Ca2+ is actively sequestered back
into the SR, which allows for relaxation and priming for the next cycle (Periasamy &
Huke, 2001). The molecular machinery that is responsible for Ca2+ release from the SR is
the ryanodine receptor (RyR; type2 isoform) complex (Bers, 2004).
The intrinsic automaticity of the sinoatrial (SA) node dictates the rate of
contraction of the heart. When an action potential (AP) is elicited, it will propagate
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through the atria, atrioventricular (AV) node, His-Purkinje system, and ventricles from
endocardial to epicardial eliciting cardiac muscle contraction in an order that is
necessary for proper pump function of the heart (Anderson et al., 2009). This order of
excitation is essential for creating pressure gradients that promote the movement of
blood into and out of each chamber. The result is efficient blood flow from the venous
return, through the respiratory circulation, and out to the systemic circulation.
Therefore, any change in the order or overall excitation of the myocardium due to
arrhythmogenesis can lead to sudden cardiac death (SCD).
Cardiac arrhythmias that originate from the ventricle, as opposed to the atria,
can severely compromise the pump function of the heart and are therefore potentially
life-threatening. These events can override the normal excitation of the sinus node,
which can be distinguished clinically on the electrocardiogram (ECG). If ventricular
tachycardia is sustained, it can devolve into fibrillation and SCD. These lethal
arrhythmias can occur as the result of an ischemic episode, myocardial infarction, or in
the failing heart (Pye & Cobbe, 1992;Gheeraert et al., 2006). The underlying
arrhythmogenic activity is frequently attributed to spontaneous action potentials due to
triggered activity (Xing & Martins, 2004), which also has the potential of initiating
reentrant tachyarrhythmias (Nattel et al., 2008;Heijman et al., 2013). Delayed
afterdepolarization (DAD), a mechanism responsible for triggered activity, is a
spontaneous depolarization of the sarcolemma that can elicit action potentials in a zone
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of the myocardium that normally has no pacemaker activity. Consequently, they can
gain automaticity and persist as an ectopic pacemaker. It has been determined that the
underlying mechanism of DADs is spontaneous Ca2+ release from the SR during diastole
(Fozzard, 1992). As a result of SR Ca2+ mishandling, Ca2+ can be extruded from the cell
via the electrogenic Na+/Ca2+ exchanger (NCX) causing depolarization of the sarcolemma
(Spencer & Sham, 2003). If this depolarization event reaches threshold of voltage gated
Na+ channels, a spontaneous action potential can be elicited and can propagate to
neighboring myocardium. Therefore, understanding the molecular mechanisms that
promote spontaneous SR Ca2+ release in heart disease is imperative for designing a
therapeutic strategy against arrhythmogenesis.

CHAPTER II: LITERATURE REVIEW
Cardiac Excitation-Contraction Coupling
Excitation-Contraction Coupling (ECC) is the cellular mechanism that connects
the electrical stimulus to the contraction of the heart. During ECC, there is a global rise
in [Ca2+]i that triggers contraction with the binding of Ca2+ to the myofilament protein
troponin C. This induces an allosteric change in the troponin-tropomyosin complex
allowing for myosin heads to form a cross bridge interaction with actin (Solaro & Rarick,
1998). Once this Ca-dependent interaction takes place, mechanical force is generated
with the hydrolysis of ATP by the acto-myosin ATPase that facilitates cross-bridge
cycling. These cycles will persist as long as [Ca2+]i is present at a sufficient concentration
or until ATP is no longer available (Goldman, 1987). In the mammalian myocardium, the
average [Ca2+]i threshold for contraction is between 0.1 µM - 0.5 µM and the half
maximal force is generated at approximately 5 µM (Endo M & Kitazawa T, 1977).
The transport systems involved in the movement of Ca2+ into and out of the
cytosolic milieu contribute directly to the activation and relaxation of the myofilaments
(Bassani et al., 1992). Furthermore, they are responsible for steady state Ca2+ within
the myocyte. This means that for a given heart rate (cardiac demand remains constant),
Ca2+ influx into the cytosol (from extracellular) during systole must be balanced by Ca2+
4
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extrusion (intracellular to extracellular) during diastole so that there is no net change in
SR Ca2+ content from each cardiac cycle (conservation of mass). This is also set by SR
Ca2+ reuptake by the SR Ca-ATPase (SERCA) and SR Ca2+ leak during diastole that is
primarily mediated by the RyR2 (Bers, 1985). Thus, the relative activity of RyR2 plays a
role in setting SR Ca2+ content on a beat to beat basis.
The Molecular Components of Cardiac Ca2+ Cycling
Activated by an influx of Ca2+ from voltage gated L-type Ca2+ channels (LTCCs)
during an AP, RyR2 mediates the release of Ca2+ from the SR during systole. This
mechanism is known as Ca-induced Ca2+ release (CICR) (Fabiato, 1983). In order for
membrane excitation to simultaneously activate SR Ca2+ release in ventricular myocytes,
sarcolemmal invaginations called transverse tubules (T-tubules) descend deep into the
myocyte. The SR forms a junction with the T-tubule creating a specialized subcellular
microdomain called the dyadic cleft that allows for efficient activation of CICR (Soeller &
Cannell, 1999). Within the dyadic cleft, RyRs and LTCCs interact in a highly organized
lattice forming a critical domain termed the couplon. The cluster of RyRs within the
couplon comprise the calcium release unit (CRU) (Franzini-Armstrong & Jorgensen,
1994;Scriven et al., 2013). It has been estimated that RyR2 complexes form clusters of
approximately 100 in size on the junctional SR membrane (Franzini-Armstrong et al.,
1999). However, the exact value currently remains a debated issue. Other investigators
have estimated RyR cluster number to be smaller in size (Hayashi et al., 2009;Baddeley
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et al., 2009). These RyR2 clusters align with LTCCs in the dyadic cleft via junctophilins
(Garbino et al., 2009). The global rise in [Ca2+]i elicited by an AP is termed the Ca2+
transient. In a ventricular myocyte, SR Ca2+ release is the result of the spatio-temporal
activation of thousands of RyR2 clusters that make up individual Ca2+ release sites. The
amplitude of the Ca2+ transient during systole is the result of local subcellular
recruitment of Ca2+ release units (Stern, 1992). SR Ca2+ release allows for a robust rise in
global [Ca2+]i, which is important for fast allosteric activation of troponin C and
myofilament contraction. During diastole, there are two major Ca2+ transport systems
that compete for cytosolic Ca; SERCA and the sarcolemmal NCX. The sarcolemmal CaATPase and the mitochondrial Ca2+ uniporter compete as well, but are considered to be
minor components (Bassani et al., 1992). Immediately after the global rise in cytosolic
Ca2+ as a result of CICR, the majority of Ca2+ is sequestered back into the SR by SERCA
and to a lesser extent is extruded from the cell by NCX. The contribution of SERCA and
NCX to decreasing [Ca2+]i during diastole is variable among species. It has been
estimated that NCX contributes only 7% to Ca2+ removal in mouse and rat myocardium
(Bassani et al., 1994;Sham et al., 1995). Whereas, in the human and rabbit myocardium,
SERCA and NCX contribute approximately 70% and 30% to cardiac relaxation,
respectively (Bers & Bridge, 1989). There are two major contributors to the Ca2+
transient in the heart; Inward Ca2+ current (ICa) and SR Ca2+ release. While ICa from the
LTCC contributes approximately 25-30% to the Ca2+ transient in the rabbit ventricle, the
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majority of Ca2+ comes from SR Ca2+ release by RyR2 (Bassani et al., 1993). At steady
state, ICa and SR Ca2+ release must be balanced by Ca2+ extrusion and SR Ca2+ uptake.
Therefore, any changes in ICa, SR Ca2+ release, SR Ca2+ reuptake, or sarcolemmal Ca2+
extrusion can have a profound effect on Ca-dependent inotropy (force) and lusitropy
(relaxation).
Sarcoplasmic Reticulum Ca2+ Release Channel
The SR is an intracellular organelle network that functions as a Ca2+ source and
sink during the systolic and diastolic phase of the cardiac cycle, respectively. Separated
into two morphologically distinct but contiguous sections, the longitudinal (nonjunctional) SR spans the length of the sarcomere and the terminal cisternae (junctional)
SR form junctions in parallel with the T-tubule (Winegrad, 1965). The junctional SR is
functionally and structurally specialized to participate in CICR (Block et al., 1988).
Concentrated here, across from sarcolemmal LTCCs, are RyR2 clusters that make up the
SR Ca2+ release sites (Lai et al., 1988). This junction forms the dyadic cleft. In addition to
the RyR2 clusters, it has been proposed that isolated or “rogue” RyRs can localize in
longitudinal or free SR (Sobie et al., 2006).
RyR2 has a relatively low selectivity given that it’s permeable to many different
divalent and monovalent cations. Furthermore, the channel has a very high
conductance of approximately 100 pS for divalent cations (Gillespie & Fill, 2008). Its
characteristically low selectivity for Ca2+ is suggested to be fundamental to its
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physiological role to produce a fast and large Ca2+ release event. While Ca2+ needs to
compete with other cations for occupancy of the channel pore, it has been proposed
that RyR2 has surface or vestibule charges that may enhance the permeation of Ca
(Mead-Savery et al., 2009;Gillespie, 2008).
Ryanodine Receptor Complex
Predominantly expressed in cardiac muscle, the type 2 isoform of RyR2 is a
tetrameric channel with a total molecular weight of approximately 564 kDa (Takeshima
et al., 1989). Activated by Ca2+ during an AP, RyR2 acts as the primary SR Ca2+ release
channel (Fill & Copello, 2002). Although Ca2+ is the central physiological activator of
RyR, other free ions and small molecules can alter its activity including Mg2+ and ATP
(Eager & Dulhunty, 1998;Masumiya et al., 2001). There are a number of proteins that
interact with RyR2 as well, each of which can modulate the channel’s activity. Proteins
that interact on the cytosolic side of RyR2 include: calmodulin, FK-506 binding proteins
(FKBP), sorcin, and Homer-1 (Balshaw et al., 2001;Bers, 2004). The two known kinases
that are scaffolded on RyR, protein kinase A (PKA) and calcium/calmodulin dependent
kinase (CaMKII), have been shown to phosphorylate RyR2 at Ser-2809 and Ser-2815,
respectively (Marx et al., 2000;Wehrens et al., 2004). Also, there are three known
associated protein phosphatases that play a role in regulating RyR2 phosphorylation
including PP1, PP2A, and PP2B. Spanning the SR membrane, but also associated with
RyR2, are the auxiliary proteins junctin and triadin. Their function is thought to be
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important for RyR’s ability to sense luminal Ca2+ ([Ca2+]SR) via interactions with the SR
Ca2+ binding protein calsequestrin (Bers, 2004). All of the aforementioned proteins that
make up the RyR2 complex are necessary for proper function of RyR2 channel activity.
While oxidative stress can directly affect RyR2, it is important to acknowledge
that oxidative stress can indirectly affect RyR2 channel activity as the result of a change
in function of associated regulatory proteins (Zissimopoulos et al., 2007;Erickson et al.,
2008;Humphries et al., 2007). For the purpose of feasibility, the scope of this work will
only examine the effect of oxidative post-translational modifications (PTMs) of the RyR.
Ca-induced Ca2+ release of RyR2
Unlike ECC in skeletal muscle, local Ca2+ entry from LTCC is an absolute
requirement for SR Ca2+ release in cardiac muscle. Fabiato and Fabiato were the first to
characterize cardiac CICR by using skinned cardiac myocytes and directly controlling Ica
(Ca2+ current) at the dyadic cleft (Fabiato & Fabiato, 1975). Further work by Fabiato
showed that SR Ca2+ release by CICR was graded, having a dependence on both time
(duration of the Ca2+ pulse) and trigger ([Ca2+] amplitude). Moreover, it was shown that
the introduction of high [Ca2+] immediately after the Ca2+ pulse trigger would cause a
decrease in SR Ca2+ release. It was concluded that this characteristic was due to a Cadependent inactivation site on the cytosolic side of RyR2 (Fabiato, 1985). While the
activation characteristics of RyR2 have since been confirmed, inactivation of RyR2 or
termination of CICR still remains controversial. A more recent study was unable to show
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that high [Ca2+]i promotes inactivation of CICR . Unlike Fabiato’s work, this study carried
out pulsatile Ca2+ uncaging in an intact cellular environment (Nabauer & Morad, 1990).
Their results suggest the existence of other CICR termination mechanisms. In vitro and
in vivo studies have shown that CICR termination, RyR2 channel activity, and channel
restitution are indeed dependent on luminal (SR) [Ca2+] (Gyorke et al., 2004;Stevens et
al., 2009;Terentyev et al., 2002;Gyorke et al., 2002;Qin et al., 2008). Furthermore, it has
been demonstrated that SR Ca2+ release terminates at a critical level of [Ca2+]SR, which is
dependent on RyR2 channel gating (Zima et al., 2008a). The fractional release of SR Ca2+
for a given [Ca2+]SR during CICR is therefore indicative of RyR2 channel activity (Bassani
et al., 1993;Bassani et al., 1995;Shannon et al., 2000a). For example, RyR2 sensitization
to cytosolic Ca2+ by the presence of 250uM caffeine results in a lower SR termination
level, increased SR Ca2+ fractional release, and increased cytosolic Ca2+ transient
(Domeier et al., 2009). These characteristics of increased RyR2 activity are suggested to
have pathological significance in the event of arrhythmogenic spontaneous SR Ca2+
waves during SR Ca2+ overload and promoting abnormally low SR Ca2+ content seen in
the failing heart (Zima et al., 2014).
Local Control, Luminal Regulation, and Inter-RyR2 Regulation
The mechanism of CICR can be logically thought of as a self-regenerative process
since Ca2+ release from the SR would diffuse throughout the dyadic cleft and activate
neighboring RyR2 clusters. If CICR was unopposed, SR Ca2+ release would continue until
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[Ca2+]SR was fully exhausted. However, during an AP, SR Ca2+ release is graded with Ica
and CICR is halted before [Ca2+]SR is entirely depleted (Zima et al., 2008a;Shannon et al.,
2003;Stern & Cheng, 2004). This suggests that the positive feedback mechanism of CICR
within the dyadic cleft is countered by channel inactivation or a termination process.
There is a general consensus that the control of CICR is a local phenomenon that is in
part due the spatial organization of RyR2 clusters within the dyadic cleft. The local
control theory, which was first described by Stern, states that CICR between RyR2
clusters is limited by physical separation as well as the high [Ca2+]i necessary to activate
a RyR2 cluster (Stern, 1992). Small increases in [Ca2+]i, however, have also been shown
to significantly increase SR Ca2+ leak in resting permeabilized myocytes (Bovo et al.,
2011). These results suggest that high local [Ca2+]i is not a limiting factor for RyR2
channel activation. Furthermore, even though [Ca2+]i is changing dynamically
throughout each cardiac cycle, SR Ca2+ leak (stochastic events immediately after an
elicited Ca2+ transient) remains relatively constant due to its dependence on [Ca 2+]SR.
The ability for RyR2 to maintain a constant leak rate with contrasting [Ca2+]i and [Ca2+]SR
during a cardiac cycle is proposed to be an essential mechanism for setting and
maintaining an appropriate SR Ca2+ load (Zima et al., 2010).
While Fabiato was the first to suggest an inactivation mechanism for RyR2
([Ca2+]i dependent), a number of other mechanisms have since been proposed that
implicate luminal regulation ([Ca2+]SR dependent) of RyR2 in the termination of CICR.

12

Without changes in RyR2 channel activity, SR Ca2+ release terminates at a critical level
that remains constant on a beat to beat basis (Domeier et al., 2009). Moreover, the
termination level observed from a single RyR2 cluster (Ca2+ spark events) also remains
constant (Zima et al., 2008a). This intrinsic property of RyR2 implies that there is the
potential for a Ca2+ sensor to exist on the luminal side of the channel. While few argue
the existence of a luminal Ca2+ binding site on RyR2 that acts as the primary [Ca2+]SR
sensor (Chen et al., 2014), multiple studies claim that the luminal Ca2+ sensing
mechanism is solely regulated by a complex made up of junctin, triadin, and
calsequestrin (Gyorke et al., 2004;Qin et al., 2008;Beard et al., 2004;di Barletta et al.,
2006). Furthermore, evidence linking the naturally occurring mutations in calsequestrin
and triadin to catecholaminergic polymorphic ventricular tachycardia (CPTV) provide
further support for the latter mechanism (Liu et al., 2006;Roux-Buisson et al., 2012).
While the dependence of SR Ca2+ release on total SR Ca2+ load is widely accepted
as fact, the theory that RyR2 activity is solely regulated by a luminal mechanism remains
highly debatable. Other mechanisms have been proposed that explain termination of
SR Ca2+ release as a RyR2 current dependent process (Yonkunas MJ et al., 2012;Guo et
al., 2012). A recently proposed theory called pernicious attrition explains the RyR2
dependence on SR Ca2+ load by the magnitude of the trans-SR Ca2+ driving force
(Gillespie & Fill, 2013), simply meaning that as RyR2 Ca2+ current increases with
increasing SR Ca2+ load, inter-RyR2 CICR within or between nearby clusters will facilitate
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SR Ca2+ release. Intuitively, as SR Ca2+ load falls, local Ca2+ release will fail to sustain
inter-RyR2 CICR leading to the termination of SR Ca2+ release. While RyR2 gating is
stochastic in nature, the decreased local Ca2+ will no longer be sufficient to activate
channels that have spontaneously closed. Therefore, any PTMs that promote the open
conformation of RyR2 or enhance the channel’s sensitivity to [Ca2+]i would likely hinder
this termination process and therefore, allow for a greater amount of SR Ca2+ release.
SR Ca2+ Leak
The RyR, being the main pathway for Ca2+ release from the SR, is responsible for
triggered (by LTCC) Ca2+ release during systole as well as non-triggered SR Ca2+ release
events during diastole. Non-triggered Ca2+ release events are referred to as SR Ca2+
leak. By definition, RyR2 channel gating is stochastic in nature (Stern, 1992;Laver et al.,
2013). The probability of RyR2 channel opening (Po) is primarily dependent on local
[Ca2+]i, but can on also be affected by a number of other factors (i.e. ATP, Mg 2+, etc.)
that have the ability to regulate channel activity (Eager & Dulhunty, 1998;Masumiya et
al., 2001). The open probability of RyR2 is described in single channel recordings as
having a value of 0<Po<1, where Po=1 is a 100% likelihood of being open. Since Ca2+ is
the main physiological activator of RyR, Po nears the value 1 when local [Ca2+]i is high
(~100 µM) at the dyadic cleft (e.g. LTCC activation). As Po approaches 1 during systole,
the SR Ca2+ release events summate to form a global Ca2+ transient. During
repolarization and relaxation of the myocardium, RyR2 Po approaches 0 as [Ca2+]i
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declines back down toward basal diastolic levels (~100nM) (Xu et al., 1998b;Rousseau &
Meissner, 1989). Tightly controlled [Ca2+]i by extrusion and reuptake machinery
promotes a low Po for RyR2, which limits spontaneous Ca2+ release from the SR and
ensures synchronized relaxation of the contractile apparatus.
SR Ca2+ leak mediated by RyR2 can occur as spontaneous Ca2+ sparks as well as
non-spark-mediated leak which is undetectable with current microscopy techniques
(Zima et al., 2010). Ca2+ sparks are elementary Ca2+ release events that arise from the
activation of individual RyR2 CRUs. These release events are observed as spatially
restricted rises in [Ca2+]i that predominantly occur at junctional SR adjacent to the zlines of sarcomeres. Cheng and colleagues were the first to visualize Ca2+ sparks in 1993
(Cheng et al., 1993). Soon after, a growing body of work described the average Ca2+
spark to increase local [Ca2+]i by approximately 200-400 nM and have a spatial width of
about 2um (Cannell et al., 1995;Lopez-Lopez et al., 1994;Satoh et al., 1997).
Spontaneous Ca2+ sparks can be observed during diastole of electrically paced isolated
myocytes as well as myocytes at rest. Experimentally, the frequency of Ca2+ spark
events can be used to determine RyR2 channel activity. While Ca2+ spark events occur
at a very low frequency in a healthy denervated myocyte, a significantly increased Ca 2+
spark propensity during diastole can be elicited by exposing myocytes to high levels of
sympathetic stimulation using the β-Adrenergic (β-AR) agonist isoproterenol (100 nM)
(Santiago et al., 2013). As the frequency of Ca2+ sparks during diastole increases over
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time, Ca2+ sparks can summate causing local [Ca2+]i to rise to a level at which
neighboring clusters become activated. Consequently, the summation and subsequent
activation of RyR2 clusters within a junction can propagate an asynchronous global SR
Ca2+ release event known as a spontaneous Ca2+ wave (SCW). The SCWs are a form of
SR Ca2+ leak that is considered sufficient to induce spontaneous APs and is therefore
considered the major substrate for DADs (Shiferaw et al., 2012;Xie & Weiss, 2009).
Cardiac Arrhythmias
Sudden cardiac death (SCD) is responsible for upwards of 50% of all deaths
associated with cardiovascular disease in the United States and other developed
countries (Reddy S.K. & Yusuf S., 1998). Ventricular tachyarrhythmias that devolve into
fibrillation are the primary cause of most SCD cases (Zipes & Wellens, 1998). Although
the electrophysiological changes are mostly understood, the molecular mechanisms that
cause these changes and the onset of life threatening arrhythmias during myocardial
stress still remain elusive.
Pathophysiology of Arrhythmias
The pathogenesis of cardiac arrhythmias is divided into three primary
mechanisms: abnormal or enhanced automaticity, re-entry of excitation, and triggered
activity. Although each mechanism can induce arrhythmias by itself, the likelihood of
multiple mechanisms acting in concert is increased as a result of cardiovascular disease.
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Abnormal automaticity is defined as an arrhythmic event in which a latent
pacemaker, a region of myocardium that exhibits automaticity properties, overrides the
intrinsic rhythm of the SA node. Enhanced normal automaticity refers to an abnormally
accelerated AP rate produced by the normal pacemakers (SA or AV node). Although all
cardiomyocytes possess intrinsic automaticity to some degree, a variety of factors can
enhance or inhibit pacemaker’s or cardiac tissue’s automaticity properties. These
factors include changes in intracellular pH, ionic imbalances (i.e. hypo/hyperkalemia calcemia), or elevated catecholamines (Mangoni & Nargeot, 2008).
The mechanism of re-entry of excitation is essentially the repetitive propagation
of an AP due to an abnormal circuit of conduction. There are two potential factors that
can generate irregular conduction pathways, allowing re-entry to manifest. The first of
these is the occurrence of an anatomical conduction block. In the case of an acute
myocardial infarction (AMI), a region of myocardium that becomes ischemic or infarcted
can either slow or block AP conduction. If an anatomical block only allows one pathway
of normal conduction (unidirectional block), an AP wave front can “re-enter” back
toward excitable tissue (relative refractory or repolarized) that lies around the
anatomical block (Kleber & Rudy, 2004). The second cause of re-entry, termed
functional re-entry, is dependent on heterogeneities in conduction and not anatomic
obstacles (Allesie MA et al., 1976). It has been suggested that the primary cause of
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these heterogeneities is abnormal channel expression/conductance as a consequence of
structural remodeling (Valderrabano, 2007;Kleber & Rudy, 2004).
Although re-entry substrates can exist in the diseased heart, they normally
remain quiescent unless electrical instability triggers them. Ectopic foci have been
implicated as the major contributor for initiating re-entry of excitation (Nattel et al.,
2008). Moreover, it is well accepted that the underlying cause for ectopic firing is both
abnormal automaticity and triggered activity.
Triggered activity
As described previously, there are multiple mechanisms that can potentially elicit
arrhythmias in disease states. Substrates for these arrhythmias include abnormal
conduction and spontaneous excitability, which can result from I/R injury or occur
during the progression to heart failure (Fozzard, 1992;Xing & Martins, 2004).
Spontaneous APs, due to triggered activity, have been implicated in initiating and
maintaining tachyarrhythmias (Kujala et al., 2012). Furthermore, there is evidence
suggesting that triggered activity from DAD is the main mechanism facilitating ectopic
foci in ischemic myocardium (Xing & Martins, 2004).
Triggered activity is defined as a spontaneous impulse that arises from an
afterdepolarization, which can potentially occur anywhere throughout the myocardium.
Although all cardiomyocytes have some degree of intrinsic automaticity, the underlying
mechanisms inducing afterdepolarizations involve the enhancement or generation of
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automaticity properties (Fozzard, 1992). Ultimately, this tissue region can become an
ectopic focus that can initiate bouts of arrhythmias.
Afterdepolarizations, the cause of triggered activity, are fluctuations in the
membrane potential or irregular depolarizations of the sarcolemma that occur following
the upstroke of an AP. If a depolarization reaches the threshold of voltage gated Na+
channels, a “triggered” ectopic AP can be generated (Zipes, 2003). Afterdepolarizations
are categorized into two types of mechanisms, which manifest at different phases
during the AP. While DADs occur once repolarization is complete (phase 4), early
afterdepolarizations (EADs) can occur during either phase 2 or 3 of the AP (Clusin, 2003).
A number of abnormal conductance properties have been implicated in the
pathophysiology of EADs including enhanced INa (Zaza et al., 2008), ICaL (Yamada et al.,
2008), and ICl (Verkerk et al., 2003) or decreased activity of IK1 (Maruyama et al., 2011).
Furthermore, it has also been shown that enhanced NCX by increased Ca2+ release from
the SR can promote EAD formation (Patterson et al., 2006). The occurrence of DADs, on
the other hand, is solely associated with enhanced NCX activity due to spontaneous Ca2+
release from the SR. Therefore, DADs occur through a SR-dependent mechanism, while
EADs can occur through both a SR- and sarcolemma-dependent mechanisms (Clusin,
2003).
Without proper AP propagation along the correct pathway of excitation, the
heart as a pump is rendered insufficient. Although arrhythmogenesis can occur through
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a number of different mechanisms, multiple mechanisms can act synergistically in the
generation and maintenance of arrhythmic episodes. While triggered activity has been
implicated as a major mechanism underlying ectopic foci, it has also been suggested to
initiate re-entry of excitation. Therefore, elucidating the molecular mechanism involved
in promoting triggered activity after an ischemic event is crucial in designing new
therapeutic strategies in the prevention of life-threatening arrhythmias.
SR Ca2+ Cycling in Heart Disease
The heart vitally relies on tightly controlled Ca2+ cycling and signaling for proper
pump function. In both ischemic and non-ischemic etiologies of heart disease, the heart
undergoes a large number of changes that contribute to the disease phenotype as well
as to the progression into heart failure. In these pathophysiological states, both the
contractile function as well as the electrical properties of the myocardium becomes
dysfunctional. Abnormal Ca2+ handling, which is a prevailing hallmark described in I/R
injury and the failing heart, is considered to be a major downstream effect that
ultimately promotes the disease phenotype (Talukder et al., 2009;Zima et al., 2014). In
the healthy myocardium, [Ca2+]i is robust and dynamic in nature allowing the molecular
machinery of the sarcomere to respond in an appropriate fashion. However, this
second messenger system is dynamic. In fact, the intrinsic ability of the myocardium to
modify the Δ[Ca2+]i and duration of each Ca2+ transient event is fundamental property of
the heart so that it can match cardiac output with the demand of the body (Lakatta,
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2004). Abnormal [Ca2+]i and [Ca2+]SR, due to impaired Ca2+ cycling machinery, promotes
both diastolic and systolic dysfunction of the heart (Zile & Gaasch, 2011). Furthermore,
the inability of the failing heart to maintain an adequate [Ca2+]SR is an important
contributor to the hearts lack of capacity to meet cardiac demand (Zima et al., 2014).
Another consequence of impaired Ca2+ cycling machinery is the increased risk for
arrhythmias. Here, the abrupt increase in [Ca2+]SR as a result of stress (e.g. β-AR) can
cause the formation of SCWs (Eisner et al., 2009).
Ischemia-Reperfusion Injury
An ischemic episode or AMI in the heart are most commonly a result of coronary
artery disease. In the event that a coronary artery becomes obstructed as a result of
atherosclerotic plaques, the downstream blood flow slows or completely ceases
creating a hypoxic environment for the non-perfused myocardium (Roberts, 1972). In
the ischemic environment, metabolites build up within the interstitium and
intracellularly due to the energy consumption of the working myocardium and the lack
of blood perfusion. Commonly associated with ischemia are complex cellular metabolic
changes including a decrease in [ATP] and a subsequent increase in free [Mg 2+], [ADP]
and inorganic phosphate ([Pi]), as well as a drop in intracellular pH (Carmeliet, 1999).
Furthermore, increased reactive oxygen species (ROS) generation is prominent as a
result of ischemic injury (Misra et al., 2009). All the aforementioned factors are known
to modulate the activity of the proteins required for intracellular Ca 2+ cycling,
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particularly the RyR. Consequently, enhanced RyR-mediated SR Ca2+ leak results in
abnormally elevated diastolic [Ca2+]i.
Depending on the degree of ischemia, infarction of the tissue can soon follow
(within minutes). Current medical interventions to restore blood flow to the ischemic
region have proven to be successful in reducing the progression of necrosis and
drastically improving mortality rates after ischemia or AMI. However, a major
complication associated with reperfusing blood to the ischemic region is the increased
risk of arrhythmogenesis (Yavuz, 2008). These bouts of arrhythmias have the potential
of initiating reentrant tachyarrhythmias, which can devolve into fibrillation and
ultimately SCD (Bunch et al., 2007).
Heart Failure
Congestive heart failure (CHF) can be simply defined as the inability for cardiac
output to meet the metabolic demand from the body. Today, CHF remains the number
one cause of hospitalization for ages 65 and older in the United States and is ultimately
the end result of cardiac remodeling due to chronic hypertension, abnormalities in
cardiac valves, or coronary artery disease (Hall MJ et al., 2008). Although the clinical
criteria for CHF are not standardized, individuals with systolic heart failure are normally
characterized as having a left ventricle ejection fraction (LVEF) less than 40%.
Individuals with diastolic HF may have an ejection fraction in the healthy range
(LVEF>55%), however, their cardiac output remains inadequate due to impaired
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ventricular filling (Dickstein et al., 2008). Researchers have documented different
cellular changes of the myocardium that prove to be dependent on the etiology of HF
(Sen et al., 2000). Cardiovascular disease risk factors can promote a variety of cellular
changes in the myocardium, which ultimately affect the development of CHF. Coronary
artery disease, a major risk factor for AMI, is the leading cause of ischemic HF.
However, increased cardiac afterload (e.g. hypertension) is a common cause of nonischemic HF (Cowburn et al., 1998). Due to progressive cardiac remodeling, patients
who suffer from CHF have a poor prognosis as well as a low quality of life. In patients
suffering from end stage CHF, death either results from pump failure or SCD (Lane et al.,
2005).
The normal healthy heart has an intrinsic inotropic property that allows for an
increase in force generation in response to increased heart rates. This is either termed
the positive force frequency response (FFR) or the Bowditch effect. This mechanism
allows the heart to increase its cardiac output so that it can meet the body’s metabolic
demand during increased stress (Lakatta, 2004). In the failing heart, however,
increasing pacing frequencies are associated with blunted FFR. This characteristic is
prominent in the failing heart and is implicated as an underlying mechanism
contributing to pump failure. While it has mostly been attributed to decreased SERCA
activity and enhanced NCX activity (Hasenfuss et al., 1996), it has also been proposed
that increase RyR2 activity can play a critical role (Kushnir et al., 2010).
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A number of abnormal electrical properties have been characterized in the
failing myocardium. One of the hallmark changes that take place in HF is a prolongation
of the AP. The cellular changes that have been implicated in AP prolongation include
alterations in Ca2+ handling, depolarizing currents, and repolarizing currents. The latter
is a notable change that is commonly observed in a number of different animal models
of HF (Tomaselli et al., 1994). In the past decade, researchers have defined changes in
the expression as well as the activity of ion channels that are involved in the cardiac AP,
particularly downregulation of outward K+ current (Ito and Ik1). As a result of diminished
repolarizing currents, the failing myocardium becomes predisposed to
afterdepolarizations (Janse, 2004). Moreover, AP prolongation is heterogeneous
throughout the failing heart, which creates an increased transmural and interventricular
dispersion of repolarization (Akar & Rosenbaum, 2003). This creates conditions
favorable for the generation of torsade de pointes, a type of triggered arrhythmia (Wu
et al., 2002).
Prolongation of the AP and abnormal conduction makes the failing myocardium
more susceptible to arrhythmogenesis. However, abnormal Ca2+ homeostasis has been
implicated as the underlying cause of arrhythmias in HF. In other words, an ectopic
impulse due to triggered activity acts as the initiating event for other mechanisms of
arrhythmogenesis (i.e. re-entry of excitation). Abnormal SR Ca2+ cycling, a hallmark of
HF, is an important contributor to the heart’s depressed contractile function and the
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increased incidence of triggered activity (Pogwizd & Bers, 2004); implicating RyR2 and
SERCA dysfunction as the primary cause. In a majority of studies, HF is associated with
increased SR Ca2+ leak and decreased SR Ca2+ reuptake mediated by RyR2 and SERCA,
respectively. However, there is conflicting evidence with respect to the contribution of
RyR2 to impaired SR Ca2+ cycling. Furthermore, pathophysiological differences have
been observed between ischemic and idiopathic HF with regards to SR Ca2+ cycling
dysfunction. A study by Sen et al. found that impaired SERCA activity was the primary
impairment in ischemic HF, whereas SERCA activity in idiopathic HF was not significantly
different when compared to healthy myocardium (Sen et al., 2000). Furthermore,
impaired SR Ca2+ release was only observed in idiopathic HF. These results suggest that
the underlying mechanisms responsible for SR Ca2+ cycling dysfunction may depend on
the etiology of HF.
Independent of the etiology, HF is commonly defined as a condition of chronic
oxidative stress due to compromised energetics. Moreover, the impaired cardiac
metabolism is considered to play an important role in the progression of disease. As the
disease progresses, oxidative stress worsens due to the increasing energy demand and
workload of the failing heart, thus perpetuating a deleterious cycle (Seddon et al.,
2007). Although HF is associated with a large number of complex changes, the focus of
this work is directed at understanding the role oxidative stress on SR Ca 2+ release. To
date, RyR2 has been characterized in HF as having an increased phosphorylation level,
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an increased oxidation level, and a decreased association of auxiliary proteins. All of the
aforementioned have been associated with increased channel activity. However, the
current understanding of oxidative modifications of RyR2 and their contribution to
defective SR Ca2+ cycling in HF remains unclear.
Oxidative Stress
Oxidative stress is a prominent feature in the onset and progression of a number
of disease states, including cardiovascular disease. Although the generation of ROS has
been shown to play an important role in normal cell signaling (Thannickal & Fanburg,
2000), during periods of oxidative stress excessive ROS production can have detrimental
effects on normal protein function and cell viability (Stadtman & Berlett, 1998).
Furthermore, increased ROS production can induce lipid peroxidation and DNA damage
that can compromise the structural and genetic integrity of the cell.
In order to counteract any ROS produced, the cell has an intrinsic antioxidant
system that allows for the breakdown of ROS into nontoxic molecules. Some of the
major components of the cellular antioxidant system include superoxide dismutase
(SOD), catalase, and glutathione peroxidase (GSHPx) (Slodzinski et al., 2008;Yamawaki et
al., 2003), which act as selective scavenging enzymes. The nonspecific antioxidants
include glutathione and thioredoxin systems. Reduced glutathione (GSH), a highly
abundant low-molecular-weight thiol, is considered the largest of the antioxidant pools
(~5mM) and is arguably the most important antioxidant system in the myocardium.
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GSH is considered the first line of defense against ROS, because it is ubiquitous
throughout all cellular compartments. Maintenance of the GSH pool by reduction of
oxidized GSH (GSSG) is carried out by glutathione reductase (Schafer & Buettner, 2001).
Oxidative stress can be simply defined as increased ROS production that
overwhelms the cellular antioxidant defense (Giordano, 2005). Depending on the
etiology of disease, oxidative stress can manifest at different time points and from
different sources. The following will review the fast onset of acute oxidative stress in IR
injury as well as the slow onset of chronic oxidative stress in HF.
Acute Oxidative Stress in Ischemia-Reperfusion Injury
It is has been well characterized that restoring blood flow to the ischemic region
drastically increases ROS production, which further increases oxidative stress. The
generation of ROS, due to an increased supply of oxygen to ischemic myocardium, has
been implicated as the underlying factor that promotes ischemia-reperfusion injury
(Vanden Hoek et al., 1996;Zweier et al., 1987). In this condition, the electron transport
chain (ETC) in the mitochondria becomes uncoupled (ETC complex I and III) and
incompletely reduces O2 forming superoxide radicals (Turrens, 1997). This sudden burst
of ROS overwhelms the intrinsic antioxidant system. The GSH/GSSG ratio can decrease
considerably during I/R (Ceconi et al., 1988;Werns et al., 1992), which can contribute to
mitochondrial ROS spill over (Aon et al., 2007;Aon et al., 2010;Brown et al., 2010).
Other sources of ROS, including NADPH oxidase (NOX), uncoupled nitric oxide synthase
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(NOS), and xanthine oxidase (XO), are also believed to play a role in I/R injury (Becker,
2004;Zweier & Talukder, 2006;Angelos et al., 2006). A recent study implicated DADs as
the major mechanism of arrhythmogenesis in a dog model of AMI. Furthermore, they
went on to show that the occurrence of DADs could be prevented with IV infusion of the
ROS scavenger TEMPOL. The results from these studies implicate oxidative stress as a
major factor in the generation of triggered activity in I/R
During myocardial infarction, excessive β-AR stimulation manifests in the
ischemic region due to elevated concentrations of catecholamines (Lameris et al., 2000).
Both ex vivo and in vivo I/R studies have shown that the main source of endogenous
catecholamines is in fact from nonexocytotic release at sympathetic nerve endings that
innervate the myocardium (Lameris et al., 2000;Kurz et al., 1995). β-AR stimulation is
considered to be an important contributor in I/R injury. Increased β -AR stimulation can
further increase energy demand and intracellular ROS production (Christensen &
Videbaek, 1974). Studies that block PKA activation via beta-blockers or direct inhibition
of PKA has proven to be effective in reducing infarct size (Makaula et al., 2005;Spear et
al., 2007). A recent study done by Nagasaka et al., showed that mitochondrial ROS
production was significantly increased in the presence of PKA catalytic subunit in
permeabilized myocytes (Nagasaka et al., 2007). Furthermore, the ROS production was
associated with a depolarization of the mitochondrial membrane potential suggesting

28

that PKA-mediated ROS production could contribute to mitochondrial dysfunction and
cardiac injury.
Chronic Oxidative Stress in Heart Failure
The mechanisms that are responsible for the progression of heart failure are
very complex and have been under intensive investigation for many years. However,
one of the common features that have been implicated to play an important role in the
pathophysiology of HF is chronic oxidative stress (Belch et al., 1991;Hill & Singal,
1997;Mallat et al., 1998). Both experimental and clinical studies have measured an
increase in ROS production in HF (Mak & Newton, 2001;Giordano, 2005;Ventura-Clapier
et al., 2004). In a mouse model of MI induced HF, Ide et al. showed that the levels of
ROS and lipid oxidation were associated with impaired mitochondrial function (Ide et al.,
2001). Furthermore, in a canine model of HF, they demonstrated that the e- transport
chain of HF mitochondria is significantly more prone to uncoupling and subsequent ROS
production (Ide et al., 1999). These results also provide evidence for a positive
correlation between depressed contractility and the level of ROS production. Chronic
oxidative stress has also been shown to manifest in HF as an imbalance of ROS
production to antioxidant defense. Furthermore, evidence has shown that antioxidant
activity progressively deteriorates in the failing heart post MI (Hill & Singal, 1997).
Furthermore, transgenic mice that have null mutations in mitochondrial SOD or
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thioredoxin develop dilated cardiomyopathy and HF, which suggests that oxidative
stress plays a primary role in the development of HF.
Oxidative Post Translational Modifications
Recent emphasis has been placed on the study of oxidative PTMs and their
important role in the regulation of RyR2 activity (Eager & Dulhunty, 1998;Xu et al.,
1998a;Marengo et al., 1998;Gonzalez et al., 2010;Sanchez et al., 2005). Elevated ROS
production, which is associated with increased cardiac demand (Heinzel et al., 2006),
has been suggested to play a role in the augmentation of SR Ca2+ release (Zima &
Blatter, 2006). Therefore, oxidative PTMs of RyR2 may function as a mechanism for
positive inotropy in the healthy heart. However, in the case of myocardial I/R or HF,
abnormally elevated ROS level can cause irregular Ca2+ cycling and, therefore, cardiac
arrhythmias (Belevych et al., 2009;Terentyev et al., 2008;Belevych et al., 2012).
In the presence of oxidative stress, free thiols of cysteine residues are the first
subjected to oxidation. Depending on the degree of oxidative stress, protein free thiols
can be oxidized by ROS to form sulfenic (R-SOH), sulfinic (R-SO2H), or sulfonic (R-SO3H)
acid products (Giles & Jacob, 2002). GSH attenuates ROS production during oxidative
stress either by directly scavenging free radicals or acting as a substrate for the major
antioxidant enzyme GSHPx. Also, GSH can readily react with protein sulfenic acids
forming the reversible PTM S-glutathionylation. The reversible reduction of Sglutathionylation is carried out mainly by the enzyme glutaredoxin (GRX). The
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formation of sulfinic and sulfonic acids, however, are considered biologically
irreversible. Thus, the formation of the protein-glutathione mixed disulfide (Sglutathionylation - PSSG) is thought to have a protective role during changes in cellular
redox state (Townsend, 2007). However, it has been proposed that S-glutathionylation
may play a role in promoting protein disulfide formation (PSSP) of both intra- and
intermolecular species (Bass et al., 2004;Cumming et al., 2004;Brennan et al., 2004).
In all tissues, the ratio between oxidized and reduced GSH (GSSG/GSH) is an
important indicator of the redox state. Changes in cellular redox environment
potentially affects the activity of many proteins, including Ca2+ channels and pumps
(Zima & Blatter, 2006). As a result, oxidative stress can potentially promote abnormally
elevated [Ca2+]i in the myocardium during diastole (Kourie, 1998;Giordano, 2005). In
cardiomyocytes, cytosolic glutathione is mainly reduced under normal physiological
conditions. During oxidative stress, however, the GSSG/GSH ratio can increase
significantly (Ceconi et al., 1988;Werns et al., 1992) as well as total protein-glutathione
mixed disulfides (Tang et al., 2011). The increased formation of glutathione mixed
disulfides is a common feature of oxidative stress due to the abundance of glutathione
and the ready conversion of reactive thiols. Recent studies have been implicated
glutathione mixed disulfides as a critical signaling mechanism that plays a causative role,
rather than a protective role, in cardiovascular disease. With respect to SR Ca2+ cycling,
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however, it is unclear if increased glutathione mixed disulfide are beneficial or
detrimental.
Cardioprotection and Nitric Oxide
Cardiac ischemia preconditioning is a phenomenon whereby short episodes of
ischemia result in cardioprotection against a severe ischemic insult. The vast body of
research studying ischemic preconditioning has yielded many different molecular
mechanisms (Zaugg et al., 2003). Given its complex nature, the crucial downstream
targets that give a tissue the ability to resist ischemic injury make up a sizeable list that
has steadily grown over the recent years. Nitric oxide (NO) signaling, an important
regulator in many physiologic processes, and subsequent protein S-nitrosylation is
commonly identified as an important molecular intermediate allowing for ischemic
preconditioning. Several cardioprotection studies defined many downstream targets of
NO, having identified the cardioprotective effect as the result of covalently linked NO
with reactive protein thiols (S-nitrosylation). These downstream targets include
proteins that are involved in mitochondrial metabolism, apoptosis, ROS defense, protein
trafficking, myofilament contraction, and Ca2+ handling. Overall, increased Snitrosylation in the myocardium is anti-apoptotic and anti-inflammatory (Sun & Murphy,
2010;Lima et al., 2010). As mentioned previously, the reperfusion of blood or
reintroduction of O2 to the ischemic tissue stimulates oxidative phosphorylation in
impaired mitochondria, which results in a burst of ROS production. Recent studies have
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found that S-nitrosylation of mitochondrial protein complexes (I, IV, and V) of the
electron transport chain (ETC) inhibits their activity, which limits oxidative
phosphorylation (Rassaf et al., 2014;Zhang et al., 2005;Sun et al., 2007). Furthermore,
S-nitrosylation of myofilament proteins decreases their sensitivity to Ca2+, decreasing
myofilament cross-bridge formation, which subsequently reduces ATP consumption
(Nogueira et al., 2009). By promoting energy conservation in the myocardium, Snitrosylation limits ROS production from uncoupled mitochondria during IR.
The cardioprotective effects of S-nitrosylation on Ca2+ machinery, although
independent, complements the effect seen in the mitochondria. In both IR and HF,
impaired Ca2+ cycling commonly leads to an increase in diastolic [Ca2+]i as well as
depleted [Ca2+]SR. In a state of [Ca2+]i overload, the diastolic function of the heart is
impaired and the likelihood of arrhythmogenesis is increased. Evidence of Snitrosylation-dependent cardioprotection has been documented for the major
components of Ca2+ cycling, preventing [Ca2+]i overload (Loyer et al., 2008). For LTCC, Snitrosylation of the channel has been shown to reduce the channel activity. Also, SERCA
activity has been reported to increase in response to S-nitrosylation. Paradoxically,
RyR2 activity has been shown to increase in response to S-nitrosylation (Gonzalez et al.,
2009). Other studies, however, showed that hyponitrosylation of RyR2 caused the
channel to be more susceptible to oxidation by ROS, leading to increased SR Ca2+ leak
and arrhythmogenesis (Gonzalez et al., 2010). Moreover, it has been suggested that S-
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nitrosylation can potentially prevent irreversible oxidation of cysteine residues (Sun &
Murphy, 2010). Thus, S-nitrosylation of RyR2 may act as a protective PTM against
oxidative stress and detrimental SR Ca2+ leak. By maintaining SR Ca2+ load and
preventing [Ca2+]i overload, S-nitrosylation plays a very important role in cardiac
function during periods of oxidative stress.
Redox Regulation of RyR2 Activity
It is well established that oxidative stress can cause ROS-induced PTMs of
proteins. The RyR2 has approximately 360 cysteine residues per tetrameric channel,
with an estimated 84 of those are in a reduced free thiol state (Xu et al., 1998a). Each
free thiol residue can serve as a target for a number of oxidative modifications including
S-nitrosylation, S-glutathionylation, or a disulfide cross-bridge. To date, a number of in
vitro studies have shown that both ROS and other free radicals can induce changes in
RyR2 channel activity (Zima & Blatter, 2006;Kawakami & Okabe, 1998). Bilayer studies
have shown that RyR2 channel activity is increased in the presence of ROS (Boraso &
Williams, 1994;Zima et al., 2004;Anzai et al., 1998). It has been proposed that oxidative
modifications, specifically S-nitrosylation and S-glutathionylation, of RyR2 can prevent
SR Ca2+ leak (Marengo et al., 1998;Bull et al., 2008;Zima et al., 2003;Boraso & Williams,
1994). Recent work from Gonzalez et al. identified that enhanced xanthine oxidase
superoxide production caused a decrease in cardiac RyR2 S-nitrosylation with an overall
decrease in free thiols promoting SR Ca2+ leak in heart failure rats (Gonzalez et al.,
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2010). Moreover, an increase in overall oxidation of RyR2 with abnormal SR Ca 2+ release
has also been observed in post-MI dog hearts (Belevych et al., 2009). Oxidation of RyR2
is also thought to play a role in myocardial preconditioning before an ischemic insult.
For example, tachycardia-induced preconditioning was proven to reduce the infarct size
after ischemia (Domenech et al., 1998). It was later identified that tachycardia
stimulated NADPH oxidase dependent S-glutathionylation of RyR, increasing RyR2 Ca2+
release and decreasing SR Ca2+ leak in SR microsomal preparations (Sanchez et al.,
2005). It still remains controversial whether or not increased channel activity (single
channel) or increased Ca2+ release rates (SR microsomes) can also coincide with
decreased SR leak within a cellular milieu.
Intersubunit Cross-linking
The protein-protein interaction between RyR2 subunits (intersubunit) has been
implicated in channel gating (Kimlicka et al., 2013;Strauss & Wagenknecht,
2013;Abramson & Salama, 1989) and therefore, likely plays a role in regulating SR Ca2+
release. In the past decade, there has been a great amount of progress in defining the
quaternary structure of RyR. Although only a small portion of the cytosolic domain has
been crystallized to date, high resolution cryo-EM studies have provided insight into
conformational changes that occur as a result of channel activation. By superimposing
the 3-D crystal structure of the N-terminal domain (RyR1 a.a. 1-532) within the 3-D
matrix created using images from cryo-EM, it was determined that the intersubunit gap
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between N-terminal domains becomes widened by ~7 angstroms in the open
conformation. These results suggest that any protein-protein interactions that are
taking place in the closed conformation, are likely disrupted as the result of channel
opening (Van, 2014). Although the N-terminal domain is only responsible for a small
portion of the intersubunit interaction, it is of particular interest because a large
number of disease mutations have been found to localize within it. In fact, a majority of
these mutations were found facing the intersubunit boundary. Here, the mutations all
had side chain properties that would consequently disrupt normal wild-type
interdomain interactions. Moreover, the mutations were all associated with a gain-offunction phenotype (increased RyR channel activity) (Kimlicka et al., 2013). These
functional results are consistent with the structural evidence, supporting the claim that
RyR channel activity is indeed affected by changes in the intersubunit interactions.
Recent work by Han et al. demonstrated that in the presence of an oxidant
(H2O2), RyR1 undergoes covalent disulfide cross-linking between neighboring subunits
(intersubunit cross-linking) that is reversible with the reducing agent DTT. In parallel,
Cryo EM images showed that RyR1, which normally has a cytosolic structure that
resembles a pinwheel, undergoes major morphological changes as a result of H 2O2
treatment. These morphological changes, however, are reversible with the treatment of
DTT (Han et al., 2006). A different cryo EM study used a non-selective crosslinking agent
(glutaraldehyde) to induce intersubunit crosslinking. In these conditions, RyR1 adopted
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a conformation that resembled that of the open state. In both these studies, the
authors suggest that intersubunit crosslinking leads to activation of RyR1 as a result of
structural changes that directly affect gating of the channel (Strauss & Wagenknecht,
2013).
Similar to other oxidative PTMs, there is functional evidence showing that intersubunit cross-linking of RyR1 is associated with increased channel activity. The
association of intersubunit cross-linking and increased channel activity was first shown
in vitro using RyR1 (Aghdasi et al., 1997). This study demonstrated with single channel
recordings of RyR1 that treatment with diamide increased channel Po and the formation
of cross-linked dimer in a dose dependent manner. The thiol alkylating agent NEM,
however, was shown to oxidize RyR1 in a multiphasic manner, which was dependent on
concentration and time. While sub-millimolar (200 µM) concentrations of NEM would
only induce an inhibitory effect of RyR1 by decreasing channel activity, sequential
treatment of NEM at millimolar (4-5mM) concentrations led to further oxidation of RyR1
causing an increase in channel activity. Most importantly, pretreatment with submillimolar NEM effectively prevented diamide induced intersubunit cross-linking. These
results suggest that the first phase of sulfhydryls, which are most susceptible to
oxidation, are involved in intersubunit cross-linking.
Abramson and Salama were the first to suggest that intersubunit cross-linking is
involved in the gating of RyR1 (Abramson & Salama, 1989). They argue that thiol
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oxidation is a necessary requirement for RyR1 channel opening. In order for this
hypothesis to be correct, the transition from conducting to non-conducting states would
have to coincide with the reduction of the principal disulfides regulating gating.
Furthermore, because the cytosolic environment is maintained at a highly reduced
state, this proposed gating mechanism assumes that dynamic disulfide formation is
present without oxidative stress. Recently, a study done by Zissimopoulos et al.
provides some biochemical evidence to support this hypothesis for both RyR1 and RyR2.
The major limitation to this study, however, was that full length RyR was not used in the
experimental approach (Zissimopoulos et al., 2013). Their work shows that N-terminal
fragments of RyR2 self-assemble into oligomers similar to that of RyR1. Interestingly,
unlike RyR1, N-terminal fragments of RyR2 were covalently linked by endogenous
disulfide bonds in ambient conditions (absence of exogenous ROS treatment). Even
though both RyR1 and RyR2 N-terminal fragments formed disulfide linked oligomers
with H2O2 in a dose dependent manner, the authors suggest that a difference in
sequence homology between isoforms may explain the disparity in disulfide bond
formation. Alternatively, if the requisite cysteine residues are in fact conserved
between isoforms, other oxidative PTMs (e.g. glutathionylation, nitrosylation) that resist
disulfide formation may be unique to RyR1.
In summary, there is a growing body of structural and functional evidence that
suggests an effect of intersubunit cross-linking on RyR2 channel gating. Although some
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work has been done to examine the effects of intersubunit cross-linking on RyR2
channel activity, no studies have examined its role in SR Ca2+ cycling within the cellular
environment. Furthermore, studies of RyR intersubunit cross-linking have focused
primarily on the skeletal isoform. In light of recent work, the susceptibility for
intersubunit cross-linking appears to be increased for the cardiac isoform of RyR
(Zissimopoulos et al., 2013). The set of experiments described in this dissertation
attempts to define a potential mechanism for RyR2 cysteine oxidation and intersubunit
cross-linking during increased protein-glutathione mixed disulfides resulting from
oxidative stress (Fig. 1). Also, I examine the incidence of intersubunit cross-linking in
models of oxidative stress in the heart. This work attempts to address the effect of
RyR2 intersubunit cross-linking on SR Ca2+ cycling in the heart during periods of
oxidative stress. Defining the contribution of RyR2 intersubunit cross-linking to SR Ca2+
leak is a necessary step in determining a mechanistic link between oxidative stress and
arrhythmogenesis. Ultimately, this research has the potential to shed light on principal
cysteine residues of RyR2 as therapeutic targets for potentiating cardiac arrhythmias.
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Figure 1. Schematic of Oxidative Stress and Cysteine Oxidation of RyR2

Top Panel, Schematic depicting increased mitochondrial ROS and
subsequent oxidation of RyR2 free thiols. GSH acts to attenuate ROS
production and react with sulfenic acid side chains. RyR2 Sglutathionylation and potentially disulfide formation are a result. Bottom
Panel, Electron cryo-microsopy image depicting RyR2 intersubunit crosslinking promoting the open conformation of the channel.

CHAPTER III: AIMS AND HYPOTHESES
The overall goal of this project is to determine the role of ROS production in the
regulation of RyR-mediated Ca2+ release under pathological conditions induced during
I/R injury and in the failing heart. Changes in PTMs of RyR2 have been implicated in
abnormal Ca2+ handling that promotes the onset and progression of cardiovascular
disease. Due to their association with many disease phenotypes, recent emphasis has
focused on the study of oxidative PTMs. Furthermore, a growing body of evidence
suggests oxidative PTMs as a potent regulator RyR2 activity (Zima & Blatter, 2006;Eager
& Dulhunty, 1998;Xu et al., 1998a;Marengo et al., 1998;Gonzalez et al., 2010;Sanchez et
al., 2005). However, little has been done to specifically characterize oxidative PTMs of
RyR2 as a result of oxidative stress within the ischemic or failing myocardium.
Moreover, it is not yet known how these modifications contribute abnormal SR Ca2+
handling and arrhythmogenesis. This project tests the following central hypothesis:
Selective oxidation of cysteine residues on RyR2 will enhance SR Ca2+ fractional
release and leak in cardiomyocytes. Oxidative PTMs of RyR2, observed as a result of
experimentally induced oxidative stress, will manifest in models of acute or chronic
oxidative stress (I/R and HF).
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Specific aim #1: Characterize RyR2 oxidation and SR Ca2+ release in vivo as a
result of increasing intracellular glutathione mixed-disulfides. Commonly observed in
many disease phenotypes, including cardiovascular disorders, is the prominence of
glutathione mixed-disulfides as the result of oxidative stress. This intrinsic ability for the
cell to buffer ROS and form reversible protein mixed disulfides with glutathione (Sglutathionylation) is imperative for protection against irreversible oxidation. However,
increased S-glutathionylation during oxidative stress is also thought to play a causative
role in the progression of cardiovascular disease. I hypothesize that increased
glutathione mixed-disulfides will promote oxidation of RyR2 favoring augmented SR Ca2+
fractional release and SR Ca2+ leak. Therefore, any elevation in SR Ca2+ load will in turn
drastically increase SR Ca2+ leak, promoting arrhythmogenic Ca2+ waves. To test this
hypothesis, changes in SR Ca2+ cycling parameters will be measured in intact myocytes.
RyR2 oxidation will be determined by measuring relative free thiol content and western
blot analysis. Prevention and reversibility of RyR2 oxidation will be determined both
biochemically and functionally. In isolated myocytes, the cellular redox environment
will be manipulated experimentally using two approaches: 1) Introduce GSSG within
permeabilized myocytes and 2) Increase intracellular GSSG/GSH ratio using the thiol
oxidant diamide.
Specific aim #2: Determine the role of RyR2 oxidation on abnormal SR Ca2+
release in I/R and HF. It is generally accepted that ischemic and non-ischemic
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cardiomyopathy are characteristically associated with oxidative stress and abnormal
Ca2+ cycling; both being associated with an increased risk of arrhythmia and have been
implicated in the progression of HF. In these studies, I will discern the redox status of
RyR2 after an ischemic insult and in the failing heart as well as the functional effect on
SR Ca2+ release. I hypothesize that oxidative stress in I/R and HF promotes the oxidation
of RyR2 favoring augmented SR Ca2+ fractional release and SR Ca2+ leak. Furthermore,
the oxidation of RyR2 will decrease frequency dependent facilitation associated with the
failing heart. To test this hypothesis, SR Ca2+ fractional release and SR Ca2+ leak will be
measured in isolated myocytes from I/R, HF, and sham hearts. RyR2 oxidation will be
determined both biochemically and functionally.

CHAPTER IV: METHODS
Chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO)
unless otherwise stated. All experiments were performed at room temperature (2224°C).
Animal Models
The use of rabbit hearts to study Ca2+ dependent arrhythmias in both I/R and HF
is important because the electrophysiology and SR Ca2+ regulation is similar to that of a
human (Bers, 2000). New Zealand White rabbits (2-2.5 kg; Harlan Laboratories,
Indianapolis, IN) received containing heparin (400U/kg) were anesthetized with sodium
pentobarbital (100 mg/kg I.V.). Experimental protocols (ex-vivo and in-vivo), animal
surgery, handling, and cell isolation were approved by the Institutional Animal Care and
Use Committee at both Loyola University Medical Center and Rush University Medical
Center.
Ex-vivo Low Flow I/R
In order to induce the effect of I/R injury globally throughout the entire heart,
rabbit hearts underwent low flow ischemia and reperfusion via ex-vivo perfusion on a
Langendorff apparatus (Langendorff Oskar, 1903). Afterwards, myocytes were isolated
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from both left and right ventricles for experiments examining RyR2 oxidation and SR
Ca2+ handling. After the
rabbit was sacrificed, the excised heart was rinsed in 1.5 mM Ca2+ Tyrode containing
heparin (1.5U/ml) and cannulated to the Langendorff apparatus and perfused at a
constant pressure of 55 mmHg at 37°C with 1.5 mM Ca2+ Tyrode without heparin for 10
minutes until stabilization of the sinus rate and the pressure of the left ventricle (LVP).
The hearts were allowed to pace at their intrinsic sinus rhythm of approximately 120180 beats/min (2-3Hz). A “pseudo-electrocardiogram” (ECG) was recorded using two
silver hook electrodes on each ventricle. LVP was measured with the aid of a latex
balloon at the end of a polyethylene catheter inserted into the left ventricle. ECG and
LVP were recorded simultaneously with an amplifier (IWorx, CB science) and LabScribe
software throughout the entire duration of the experiment. Changes in sinus rate,
propensity of arrhythmia, and LVP was monitored throughout. Low flow ischemia was
carried out by reducing the perfusion flux to approximately 5% of baseline for 30 min.
The initial flow was then restored for 15 minutes (reperfusion). In hearts that were used
solely for glutathione ratio analysis, tissue biopsies were collected from ventricular
myocardium before and after low flow I/R. Tissue biopsies were excised using a circular
punch blade so that both endo- and epicardial regions of the ventricular wall were
included.
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Ex-vivo Coronary Ligation I/R
Local I/R injury was performed using coronary ligation on excised rabbit hearts
via ex-vivo perfusion on a Langendorff apparatus. Afterwards, tissue was isolated from
the left ventricle, flash frozen in liquid nitrogen, and later homogenized for biochemical
analysis examining RyR2 oxidation. Excised hearts were rinsed in 1.5 mM Ca2+ Tyrode
containing heparin (1.5U/ml), cannulated on the Langendorff, and perfused at a
constant pressure of 55 mmHg at 37°C with 1.5 mM Ca2+ Tyrode without heparin for 10
minutes until stabilization of the sinus rate and LVP. The hearts were allowed to pace at
their intrinsic sinus rhythm and monitored with ECG. ECG and LVSP were recorded as
described in the low-flow I/R protocol. Local ischemia was carried out by ligating the
left anterior descending coronary (LAD) using a 5-0 polypropylene suture (Ethicon, USA).
The suture was tightened around the LAD and tied around a small piece of polyethylene
tubing, inducing ischemia. After 30 min ischemia, the tubing was removed and the
coronary ligature was released allowing for reperfusion of the ischemic myocardium for
15 min. Tissue was isolated from ischemic (downstream of coronary) and remote zones
from the left ventricle.
Non-Ischemic HF
The HF myocytes used in the presented studies were isolated from a rabbit HF
model that was implemented by Dr. Lothar A Blatter, from Rush University. New
Zealand White rabbits (Harlan Laboratories, Indianapolis, IN) undergo two separate
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surgeries to induced hypertrophy and HF (a combined insult of aortic insufficiency and
constriction was used to induce left ventricular volume and pressure overload,
respectively). This model has shown to produce many similar symptoms of human HF
including non-reentrant ventricular arrhythmias. Aortic insufficiency was performed by
puncturing the aortic valve with a beveled 5-Fr micropuncture introducer, which was
introduced through the left carotid artery and guided by echocardiography. Twodimensional echocardiography was used to confirm and determine the degree of aortic
valve insufficiency. Two weeks later, aortic constriction was performed on the
abdominal aorta proximal to the renal arteries. Depending on the severity of aortic
insufficiency, a 4-0 silk thread was tightened around the aorta in order to reduce the
diameter between 25-40%. The progression of hypertrophy and HF was monitored
using echocardiography at 2 to 4 week intervals after both surgeries. All parameters
were calculated relative to the baseline measurements taken prior to the surgeries. The
development of hypertrophy and the subsequent onset of HF was carried out over the
course of approximately 5-8 months. Once left ventricular end-diastolic diameter was
increased >50% and left ventricular fractional shortening was decreased by
approximately 40% (depending on morbidity), hearts were categorized as HF. Rabbits
were sacrificed and single cardiomyocytes were isolated.
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Myocyte Isolation
Ventricular myocytes were isolated from sham (control), I/R, and HF rabbit
hearts. Following thoracotomy hearts were quickly excised, mounted on a Langendorff
apparatus. Ex-vivo sham or I/R protocols were carried out as described previously. All
hearts were then retrogradely perfused with nominally Ca2+ free Tyrode solution for 5
min, preventing CICR and relaxing the muscle. In sequence, minimal essential medium
Eagle (MEM; 9.7g/L), 20 μM Ca2+ (CaCl2), Liberase Blendzyme (45 μg/ml; Roche Applied
Science, IN, USA)-containing solution at 37°C was perfused for 16 min. Atria were
removed from the heart, followed by the aorta and residual connective tissue. The free
wall of the left ventricle was separated from the septum and the right ventricle. Each
ventricle was then lightly minced (~5 pieces), gently shaken, filtered, and washed in a
MEM, 50 μM Ca2+, and 10 mg/ml bovine serum albumin-containing solution at 37°C.
Viable myocytes were settled for 10-12 minutes in conical tubes and then resuspended
in MEM, 50 μM Ca2+ -containing solution at room temperature (22–24°C). Using slow
capillary action, isolated myocytes were re-equilibrated to ~1-1.5 mM Ca2+ using 2 mM
Ca2+ Tyrode solution.
Confocal Microscopy
Changes in [Ca2+]i and [Ca2+]SR were measured with laser scanning confocal
microscopy (Radiance 2000 MP, Bio-Rad, UK) equipped with a ×40 oil-immersion
objective lens (N.A.=1.3).
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Measurements of [Ca2+]i
To record [Ca2+]i we used the high affinity Ca2+ indicator Fluo-4 (Molecular
Probes/Life Technologies, Grand Island, NY). To load the cytosol with Ca2+ indicator,
cells were incubated at room temperature with 10 µM Fluo-4/AM for 15 minutes in
Tyrode solution (in mM: NaCl 140; KCl 4; CaCl2 2; MgCl2 1; glucose 10; HEPES 10; pH 7.4),
followed by a 20 minute wash. Fluo-4 was excited with the 488 nm line of an argon laser
and fluorescence was measured at >515 nm with a photomultiplier tube after passing
through a 515-nm long-pass filter. Action potentials were induced by electrical field
stimulation using a pair of platinum electrodes, which were connected to a Grass
stimulator (Astro-Med. Inc., USA) set at a voltage ~50% above the threshold. Fluo-4
recordings were acquired in line-scan mode (3 ms per scan; pixel size 0.12 µm). SR Ca2+
load was measured from the peak amplitude of the [Ca2+]i transient induced by the
rapid application of 10 mM caffeine.
Measurements of [Ca2+]SR and SR Ca2+ leak
To record [Ca2+]SR we used the low affinity Ca2+ indicator Fluo-5N (Molecular
Probes/Life Technologies, Grand Island, NY). To load the SR with Ca2+ indicator,
myocytes were incubated with 5 µM Fluo-5N/AM for 2.5 hours at 37°C.
For intact cell experiments, action potentials were induced by electrical field
stimulation using a pair of platinum electrodes, which were connected to a Grass
stimulator (Astro-Med. Inc., USA) set at a voltage ~50% above the threshold for
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contraction. To avoid motion artifacts, the scan line was positioned along the short axis
(transversal scan) in the central region of the cell where cell motion is minimal during
contraction. Stimulation frequency was 0.5 Hz. Changes in [Ca2+]SR were calculated by
the formula (Cannell et al., 1994): [Ca2+]SR = Kd × R/(Kd/[Ca2+]SR diast - R + 1), where R was
the normalized Fluo-5N fluorescence (R = [F-Fmin]/[F0-Fmin]); F0 and Fmin where the
fluorescence level at rest and after depletion of the SR with caffeine (10 mM),
respectively. The Kd (Fluo-5N Ca2+ dissociation constant) was 390 μM based on in situ
calibrations (Zima et al., 2010), and [Ca2+]SR diast (diastolic [Ca2+]SR at 0.5 Hz) was 800 μM
(Shannon et al., 2003).
Fluo-5N/AM loaded myocytes were permeabilized with saponin (0.005%) to
remove cytosolic Fluo-5N. In order to avoid photobleaching, Fluo-5N was excited with a
low laser energy (0.5% Argon). To improve the signal-to-noise ratio of the low intensity
Fluo-5N signal, fluorescence was collected with an open pinhole and averaged over the
entire cellular width of the 2-D image. The saponin-free cytosolic solution was
composed of (in mM): K-aspartate 100; KCl 15; KH2PO4 5; MgATP 5; EGTA 0.35; CaCl2
0.12; MgCl2 0.75; phosphocreatine 10; HEPES 10; creatine phosphokinase 5 U/ml;
dextran (MW: 40,000) 8%, and pH 7.2 (KOH). Free [Ca2+] and [Mg2+] of this solution
were 150 nM and 1 mM, respectively (maxchelator.stanford.edu). SR Ca2+ leak was
calculated as a function of [Ca2+]SR ([Ca2+]SRT) over time (d[Ca2+]SRT/dt) after inhibiting
SERCA with TG. [Ca2+]SRT was calculated as: [Ca2+]SRT = Bmax/(1 +Kd/[Ca2+]SR) + [Ca2+]SR;
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where Bmax and Kd were 2700 μM and 630 μM, respectively (Shannon et al., 2000c). The
rate of SR Ca2+ leak (d[Ca2+]SRT/dt) was plotted as a function of [Ca2+]SR for each time
point (15 s) during [Ca2+]SR decline. Changes in SR Ca2+ leak are presented as relative
changes in the rate of leak (d[Ca2+]SRT/dt) for a given [Ca2+]SR bin. The complete SERCA
inhibition was confirmed by measuring [Ca2+]SR recovery after SR Ca2+ depletion with
caffeine and then [Ca2+]i elevation to drive Ca2+ uptake. Fmin was measured after
depletion of the SR with 10 mM caffeine in the presence of 5 mM EGTA. After Fmin was
determined, cells were pretreated with the myosin inhibitors (blocking myofilament
cross-bridge cycling) 2,3-butanedione monoxime (10 mM) and blebbistatin (10 μM) for
approximately 5 min in order to prevent irreversible myocyte contraction during
application of high [Ca2+] during Fmax. Fmax was measured following an increase of [Ca2+]
to 10 mM in the presence of caffeine. Caffeine keeps RyRs open allowing [Ca 2+]
equilibration across the SR membrane (Shannon et al., 2003). The Fluo-5N signal was
converted to [Ca2+] (Free Ca2+) using the formula: [Ca2+]SR = Kd(F-Fmin)/(Fmax-F), where Kd
was 390 µM. SR Ca2+ leak was measured as the changes of total [Ca2+]SR ([Ca2+]SRT) over
time (d[Ca2+]SRT/dt) after complete SERCA inhibition with thapsigargin (TG; 10 μM).
All 2-D and line scan measurements for [Ca2+]i and [Ca2+]SR were analyzed with
ImageJ software (NIH, USA). Spark properties from line scan measurements were
analyzed using the ImageJ plugin Sparkmaster (Picht et al., 2007).
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ROS Production Measurements
Relative changes in the cellular level of ROS was measured within intact
myocytes using the ROS-sensitive fluorescent dye, 5-(and-6)-chloromethyl-2′,7′dichlorodihydrofluorescein diacetate (H2DCFDA; Molecular Probes/Life Technologies,
Grand Island, NY). Myocytes were incubated in 20 μM H2DCFDA, 2 mM Ca2+ Tyrode
solution for 40 min at room temperature, entrapping the dye within the cytosol.
H2DCFDA excitation (~450-500nm) was carried out using the 488 nm line of an argon
laser and the emitted fluorescence (~510-570nm) was collected using a PMT via a long
pass filter transmitting wavelengths >510nm. Live 2-D recordings were acquired at 15 s
intervals. The fluorescence intensity (F) was determined by integrating the fluorescence
for the entire volume of the cell. The ROS level (arbitrary units) was presented as the
normalized fluorescence (F/F0), where F0 is the baseline fluorescence recorded during
the initial 2-D scan. All experiments were performed using the lowest laser power
available (0.5%) and fluorescence was collected with an open pinhole in order to ensure
that photoproduction of ROS by laser illumination was minimized. The rate of ROS
production was estimated by the slope of a fitted linear function to the H2DCFDA signal
(d(F/F0)/dt). Relative differences in the rate of ROS production under different
experimental conditions were determined as a percentage. To ensure specificity for
cytosolic ROS, the application of ROS scavenger Tiron was used to limit endogenous ROS
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production. Exogenous H2O2 (1mM) was applied as a positive control as well to
determine a standardized rate of ROS production.
RyR2 Single Channel Recordings
SR vesicles isolated from rabbit ventricle were incorporated into planar lipid
bilayers and RyR2 channel activity was measured. For recording of Cs+ currents through
RyRs, the cis- and trans-chambers contained (mM): CsCH3SO3 400; CaCl2 0.1; Hepes 20;
pH 7.3. The cis- and trans-chambers corresponded to the cytosolic and luminal side of
the RyR2 channel, respectively. After fusion of vesicles and incorporation of RyR
channels, Free [Ca2+] in the cis-chamber was adjusted to 3 µM by adding an appropriate
amount of EGTA. Single channel currents were recorded with an Axopatch 200B
amplifier (Axon Instruments, Foster City, CA) at a holding potential of -20 mV. Currents
were filtered at 1 kHz and sampled at 5 kHz. The mean open probabilities (P o) of the
channels were used as an index of activity. Po values were calculated from the 50%
threshold analysis using pClamp software (Axon Instruments).
Measurements of RyR2 Intersubunit Cross-Linking and S-Glutathionylation
Alteration in the electrophoretic mobility of the 560 kDa subunit (measured with
34C primary antibody; DSHB, USA) was used to detect RyR2 cross-linking between
subunits (~1MDa) (Aghdasi et al., 1997). A specific antibody raised against GSH was
used to determine RyR2 S-glutathionylation (1:10000; Virogen). Previous studies have
proven its ability to detect RyR2 S-glutathionylation levels (Aracena-Parks et al.,
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2006;Bull et al., 2008). Whole tissue isolations were minced and homogenized using a
glass mortar and pestle in a buffer solution containing Tris-maleate (10 mM), NaCl
(0.5%), and protease inhibitor cocktail (Roche Applied Science, IN, USA) at a pH of 6.8.
All myocytes used in these experiments were freshly isolated and treated in suspension.
Intact ventricular myocytes were treated with diamide in Tyrode solution for 5 min.
Permeabilized myocytes were treated with either GSH or GSSG (5mM) in internal
solution for 5 min. Myocytes were pelleted via centrifugation and lysed in non-reducing
Laemmli buffer containing N-ethylmaleimide (5 mM) to block free sulfhydryl groups.
The addition of 200 mM DTT was used to confirm reversibility of RyR2 cross-linking and
to be used as a reference for total RyR. Lysate samples were incubated at 70°C for
10min, ran on 3-15% SDS-PAGE, and transferred onto nitrocellulose membrane using
Tubo-transfer (Bio-Rad, USA). Immunoblot against RyR2 was carried out using the
monoclonal 34C primary antibody (1:1000) (DSHB, USA) and anti-mouse HRPconjugated secondary antibody (1:5000) (Santa Cruz, USA). Western blots were
quantified using the UVP EpiChemi imaging system (BioRad, USA) and ImageJ software
(NIH, USA). Relative RyR2 cross-linking was analyzed as ((Total RyR2 - Monomeric RyR) /
(Total RyR)).
Functional studies examining the contribution of S-glutathionylation on SR Ca2+
leak (confocal microscopy), introduced GSH (5mM) and human recombinant
glutaredoxin-1 (5 units/µL) (Cayman Chemical, USA).
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Free Thiol Content Measurement of RyR
The content of free thiols in RyRs was measured using the irreversible alkylating
agent monobromobimane (mBB), which becomes fluorescent once it reacts with a free
thiol. Previous studies have demonstrated the efficacy mBB for detecting free thiols,
including those on RyR2 (Kosower & Kosower, 1987;Terentyev et al., 2008). All
myocytes used in these experiments were freshly isolated from HF, sham, and I/R and
treated in suspension. To determine the relative free thiol content, maximal free thiols
(entirely reduced) was determined by treating myocytes with the reducing agent
dithiothreitol (DTT; 5 mM). As a baseline fluorescence (entirely oxidized), myocytes
were incubated with the oxidizing agent 2.2’-dithiodipyridine (DTDP; 0.5 mM). After
treatment for 5 min, myocytes were permeabilized with saponin (0.005%) for ~30 sec so
that mBB (400 μM) can be introduced intracellularly. Myocytes were incubated with
mBB for one hour and then washed 3 times in order to remove unbound label and GSH.
Myocytes were then lysed in reducing Laemmli Buffer (containing 10% 2mercaptoethanol) and equally loaded and ran out on 4-15% SDS-PAGE. The gel was first
imaged using UV light to measure mBB emission (490 nm) with the UVP EpiChemi
imaging system (BioRad, USA). Afterwards the gel was stained with Coomassie Blue in
order to normalize the mBB signal to total RyR2 protein.
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Glutathione Ratio Assay
The severity of oxidative stress was determined from Sham and I/R tissue
biopsies isolated before and at the end of each protocol. Tissue biopsies were
homogenized using a bead-beater homogenizer (Biospec Products; USA) and the
resulting homogenate protein concentration was determined using Coomassie Bradford
assay (Thermo; USA). The addition of 5-sulfo-salicylic acid dihydrate (5% w/v) was used
to precipitate protein from homogenate samples. Samples were vortexed, incubated on
ice for 10 min, and centrifuged at 14,000 rpm at 4°C for 10 minutes. The resulting
supernatant was used for analysis of GSSG/GSH content. The concentration of GSH was
defined using a fluorometric glutathione detection assay (Arbor Assay K006), utilizing a
fluorescent label that covalently binds to GSH. The sample fluorescence was measured
using a fluorometer (OLIS DM 45, USA) at an excitation/emission of 390/510 nm. A
standard plot of known GSH concentrations was developed before each set of
experiments. After GSH fluorescence was determined for each sample, the subsequent
reduction of GSSG by glutathione reductase would yield total GSH fluorescence.
Absolute concentrations were determined based on the linear fit of the standard
fluorescence. Absolute GSSG concentration was quantified as ((Total GSH - Free GSH) /
2). Values presented are percent changes in GSSG/GSH.
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HEK293 Ca-Induced Ca2+ Release Model
Using HEK293 cells grown on glass coverslips cultured in 2%FBS MEM,
recombinant human RyR2 and SERCA2a were co-expressed via polyethyleniminemediated transient transfection (PEI; 1μg/ml). Cloned cDNA encoding human GFPRyR2wt was kindly provided by Dr. Christopher George (University of Cardiff, UK) and
CFP-SERCA2a was kindly provided by Dr. Seth Robia (Loyola University Chicago). This
approach was also employed so that differences in redox sensitivity of the RyR2 mutant
(C3602A) and RyR2wt could be assessed. Before each experiment, HEK293 cells
cultured on a glass coverslip were loaded into a chamber and washed in relaxing
solution containing (in mM): potassium aspartate 150; MgCl2 0.25; EGTA 0.1; HEPES 10;
pH 7.2. Using confocal microscopy to measure [Ca2+]i, HEK293 cells were permeabilized
with internal solution containing saponin (0.005%). The saponin-free internal solution
contained the high affinity Ca2+ indicator Rhod-2 tripotassium salt (40 μM) and included
(in mM): K-aspartate 100; KCl 15; KH2PO4 5; MgATP 5; EGTA 0.35; CaCl2 0.12; MgCl2
0.75; phosphocreatine 10; HEPES 10; creatine phosphokinase 5 U/ml; dextran (MW:
40,000) 8%, and pH 7.2 (KOH). Free [Ca2+] and [Mg2+] of this solution were 300 nM and
1 mM, respectively. Prior to the experiments, the free [Ca2+] was established by
introducing increments of 50 nM free [Ca2+] in a step wise manner until spontaneous
Ca2+ waves (SCW) were induced. Only HEK293 cells co-expressing RyR2wt and SERCA2a
produced SCW and did not occur in cells expressing RyR2wt without expressing SERCA2a
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(and vice versa). Recorded [Ca2+]i fluorescence was normalized to the initial baseline
fluorescence (F/F0). The mean amplitude and propensity for SCWs was calculated as a
relative change during treatment compared to control steady state. Mean values
calculated in control for each cell were normalized to 100%.
Statistics
Data are presented as mean +/- standard error of the mean (SEM) of n
measurements or averaged values from each myocyte isolation. Statistical comparisons
between groups were performed with the Student's t test for paired or unpaired data
sets. Differences were considered statistically significant at P<0.05. Comparisons
among multiple sample groups were performed with one way analysis of variance
(ANOVA). Statistical analysis and graphical representation of averaged data was carried
out on OriginPro7.5 software (OriginLab, USA).

CHAPTER V: RESULTS
AIM #1: Characterize RyR2 oxidation and SR Ca2+ release in vivo as a result of increasing
intracellular glutathione mixed-disulfides
Determining Endogenous ROS Levels in Stressed Myocytes
In order to determine a physiologically relevant concentration of H2O2
treatment, oxidative stress was simulated in isolated ventricular myocytes. Using
fluorescence microscopy, direct measurements of cytosolic ROS level was done using
the irreversible fluorescent ROS indicator H2DCFDA (DCF).
In order to induce oxidative stress, myocytes were stressed under supramaximal
β-AR stimulation. Excessive β-AR stimulation, which is associated with AMI, has been
implicated as an underlying factor that can promote oxidative stress. As described
previously by Bovo and colleagues, supramaximal β-AR induces a significant increase in
ROS production that coincides with the onset of SCWs in electrically paced myocytes.
Moreover, the authors determined that scavenging ROS prevented the onset of SCWs
(Bovo et al., 2012). These results suggest that the concentration of intracellular ROS
produced during β-AR stress was sufficient to promote abnormal SR Ca2+ handling.
In paced (0.75 Hz) myocytes loaded with DCF, the rate of ROS production was
measured (Fig. 2A) before and after the application of isoproterenol (0.1µM). Since the
initial rise in ROS production is not evident until 6-8 min during β-AR stimulation,
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Figure 2. ROS Production in Ventricular Myocytes During β-AR Stimulation

A, Representative DCF fluorescence plot measuring intracellular ROS
production during isoproterenol (0.1 µM) application in myocytes treated
with and without MnTBPA (25 µM). B, ROS production was measured
relative to baseline fluorescence as a percentage. n=4 (11 myocytes total)
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DCF fluorescence was recorded for approximately 15 min of isoproterenol treatment in
order to establish a relative change in ROS production. At the end of each experiment,
the myocytes were then perfused with 1mM H2O2 in order to determine a standardized
rate of change in DCF fluorescence for a given concentration of ROS. We performed
analysis on the linear rate of ROS production during isoproterenol treatment relative to
that of the external application of H2O2 (Fig. 2B). Based on the resulting percentage
(~10%), overall ROS concentration during β-AR stimulation was estimated to be
approximately 100µM. Here, our estimate of ROS concentration in stressed myocytes
did in fact corroborate the existing literature as a physiologically relevant concentration
of ROS during oxidative stress (Stone & Yang, 2006).
Effects of Oxidants on SR Ca2+ Fractional Release and Leak
In order to assess the effect of oxidative stress on SR Ca2+ handling, the first
experimental approach examined RyR-mediated SR Ca2+ release in isolated myocytes
before and after oxidant treatment. Here, my aim is targeted toward defining a
molecular mechanism that links oxidative stress and abnormal RyR2 activity. Using the
Ca2+ indicator Fluo-4AM, cytosolic [Ca2+]i was measured in isolated ventricular myocytes
paced at 0.75 Hz using field stimulation (Fig. 3A). SR Ca2+ load was measured as the
amplitude of the Ca2+ transient induced by caffeine (10 mM) application, whereas LTCC
contribution was estimated from the amplitude of the AP-induced Ca2+ transient during
the application of caffeine. Because the SR is completely depleted of Ca2+ in the
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Figure 3. SR Ca2+ Fractional Release from Cytosolic and SR Ca2+ Fluorescence
Measurements in Isolated Ventricular Myocyte

A, Representative plot of Fluo-4 fluorescence measuring cytosolic Ca2+ during field
stimulation (red arrows) and caffeine induced release of SR Ca2+ content. LTCC
contribution was determined by field stimulation after SR Ca2+ depletion (caffeine;
10mM). RyR2 contribution was calculated subtracting LTCC from the Ca2+
transient elicited before caffeine application. SR Ca2+ fractional release was
determined by dividing RyR2 contribution by total SR Ca2+ content (caffeine).
B, Representative Fluo-5N measure of SR Ca2+. SR Ca2+ fractional release was
calculated as the amount of Ca2+ released from the SR relative to the total SR
Ca2+ content ((diastolic [Ca2+]SR - [Ca2+]SR termination) / diastolic [Ca2+]SR). C, Fluo4 fluorescence measuring LTCC Ca2+ transient after blocking LTCC with
Nifedipine(5 µM).
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presence of 10mM caffeine, the AP-induced Ca2+ transient during caffeine application is
mainly mediated by LTCC (Bovo et al., 2013). In order to determine if reverse mode of
NCX contributed to electrically induced Ca2+ transients after SR depletion, myocytes
were treated with LTCC blocker nifedipine (5uM) in a separate experiment (Fig. 3C). No
measurable Ca2+ transients could be elicited after 3 min of nifedipine treatment
suggesting that the contribution of reverse-mode of NCX was undetectable.
With the application of 50 µM H2O2 (Fig. 4A), there was a tendency (~50% cells)
for Ca2+ transient amplitudes to increase within the initial minutes of treatment
suggesting that H2O2 was having a positive inotropic effect with respect to SR Ca2+
cycling. This effect diminished over time as both transient amplitude and SR Ca2+ load
decreased suggesting that SR Ca2+ leak was prevailing over reuptake. Furthermore,
basal diastolic [Ca2+]i tended to be elevated during treatment. Although SR Ca2+ content
diminished over time, the resultant SR fractional release was significantly increased
after treatment. In a parallel study, we determined changes in [Ca2+]SR termination (SR
Ca2+ depletion during an AP), which is a direct measurement of RyR-mediated SR Ca2+
release (Fig. 4B). This was done by measuring changes in [Ca2+]SR during field stimulation
using myocytes with Fluo-5N entrapped within the SR. With respect to steady state
control (5 min before treatment), SR Ca2+ load (diastolic [Ca2+]SR) did not significantly
change after 5 min of H2O2 treatment. [Ca2+]SR termination, however, was significantly
decreased (0.30 ± 0.05). Thus, the calculated SR Ca2+ fractional release was significantly
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Figure 4. SR Ca2+ Fractional Release with H2O2 Treatment

A, Representative traces of Ca2+ transients before and during H2O2
application (50 µM; 5 min). B, Representative traces of [Ca2+]SR depletions in
a ventricular myocyte before and during H2O2 application. C) Average data
for relative diastolic [Ca2+]SR, [Ca2+]SR termination, and SR Ca2+ fractional
release after 5 min H2O2 treatment. *P<0.05; n=3 (6 myocytes total)
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increased (0.68 ± 0.04; Fig. 4C). The tendency for SR Ca2+ load to decrease over time
with H2O2 treatment (Fluo-4A; Caffeine transient) did agree with SR Ca2+ measurements.
H2O2 can potentially oxidize a number of different protein residues including the
two most susceptible to oxidation, cysteine and methionine. Furthermore, H2O2 is
known to readily react with phospholipids and therefore, can potentially damage the
integrity of the cell membrane. Although the use of H2O2 experimentally is
physiologically relevant in the study of oxidative stress, it is highly reactive (fatty acid
oxidation, methionine oxidation, etc.) and can complicate the experimental results as
well as defining a molecular mechanism. Therefore, a more selective oxidant approach
was used in the following experimental designs.
Diamide, a diazine carbonyl compound, is a chemical oxidant that has been
shown to be selective for sulfhydryl groups (i.e. protein thiols; R-SH). In particular,
diamide has been demonstrated to be a potent chemical oxidizer of the cellular GSH
pool (Kosower et al., 1972) and can selectively induce oxidative PTMs on cysteine
residues of proteins. In order to identify the effects of thiol oxidation on Ca 2+ cycling in
electrically paced (0.75 Hz) myocytes, cytosolic [Ca2+] and SR Ca2+ load was measured
before and after the treatment of diamide. In the presence of diamide (25 µM), Ca 2+
transient amplitude remained relatively unchanged (Fig. 5A). However, SR Ca2+ load was
decreased (by 25%) and LTCC-mediated transient amplitude was elevated (by 16%). The
effect on [Ca2+]i by diamide fully developed 1 min after diamide application and was not
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Figure 5. SR Ca2+ Fractional Release with Diamide Treatment

A, Representative traces of Ca2+ transients before and during diamide
application (25 µM; 5 min). B, Representative traces of [Ca2+]SR depletions in
a ventricular myocyte before and during diamide application. C) Average
data for relative diastolic [Ca2+]SR, [Ca2+]SR termination, and SR Ca2+ fractional
release after 5 min diamide treatment. *P<0.05; n=5 (9 myocytes total)
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reversible after washout. These results suggest that diamide increases fractional SR Ca 2+
release and depletes SR Ca2+ load.
In order to determine if diamide affects other components of Ca 2+ handling,
[Ca2+]i decline was analyzed during the AP-induced and caffeine-induced Ca2+ transients
under control conditions and in the presence of diamide. The decline of [Ca 2+]i during
the caffeine application is due to Na+-Ca2+ exchange (NCX), whereas during the APinduced Ca2+ transient [Ca2+]i declines as the result of the combined activities of SR Ca2+
-ATPase (SERCA) and NCX (Bassani & Bers, 1994). Diamide slightly accelerated the
decline of the AP-induced Ca2+ transients (by 19±8%), but did not affect the kinetics of
the caffeine-induced Ca2+ transient. These results suggest that diamide stimulates
SERCA-mediated SR Ca2+ uptake, but not NCX-mediated Ca2+ extrusion.
Determining the contribution of RyR2-mediated Ca2+ release by measuring [Ca2+]i
alone was not sufficient since LTCC-mediated Ca2+ transient amplitude did not remain
constant with the application of diamide. Therefore, changes in [Ca2+]SR depletion were
determined using field stimulated myocytes with Fluo-5N entrapped within the SR (Fig.
5B). In the presence of 25 µM diamide, diastolic [Ca2+]SR (0.56 ± 0.07) as well as relative
[Ca2+]SR termination level (0.28 ± 0.04) decreased significantly, which resulted in an
increased fractional SR Ca2+ release (0.52 ± 0.03; Fig. 5C). Therefore, these results
indicate that RyR-mediated SR Ca2+ release is significantly increased with the application
of the oxidant diamide.
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Effect of Thiol Oxidation on Steady State [Ca2+]SR
Since SR Ca2+ load is highly dependent on RyR-mediated SR Ca2+ leak, steady
state diastolic [Ca2+]SR was measured with increasing oxidation of RyR2 by diamide.
Here, our approach was to superfuse myocytes with increasing concentrations of
diamide (10, 50, and 500 µM) while measuring diastolic [Ca2+]SR in field-stimulated
myocytes (0.5 Hz). We found that increasing concentrations of diamide up to 50 µM
caused a decrease in diastolic [Ca2+]SR (10 µM: 48.75% ± 2.2; 50 µM: 30.5% ± 3.2; 500
µM: 30.0 ± 2.8; Fig. 6C). The relative change in diastolic [Ca2+]SR in the presence of
diamide (at steady state) was calculated as a percentage of control [Ca2+]SR (Fig. 6D).
When increasing concentrations of diamide were applied in sequence (Fig. 6C), the
application of 500 µM diamide had no additional effect on [Ca 2+]SR suggesting that the
effect due to oxidation is already maximal at 50 µM diamide. The alkylating agent Nethylmaleimide (NEM; 500 µM) has been shown previously to irreversibly block reactive
sulfhydryls skeletal RyR2 type 1 (2). Here, myocytes were perfused with NEM (500 µM)
for 1min before the application of diamide. With the application of NEM, diastolic
[Ca2+]SR increased initially and gradually fell back toward control levels. Consequently,
the application of diamide had no effect on diastolic [Ca2+]SR after NEM application (Fig.
7). The previous results suggested that oxidation of SERCA by diamide increases SERCA
activity. Thus, thiol oxidation of RyR2 by diamide decreases diastolic [Ca2+]SR
presumably by stimulation of RyR-mediated Ca2+ leak (not compensated by SERCA).
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Figure 6. RyR2 Oxidation and Diastolic [Ca2+]SR with Diamide Treatment

A, Western immunoblot (non-reducing) against RyR2 from total lysate of
isolated myocytes subjected to different concentrations of diamide (5
min). For each sample, the reducing agent DTT (200 mM) was added in
order to measure total RyR. B, Relative RyR2 cross-linking in the presence
of diamide (*P<0.05; n=3). No measureable cross-linking is observed in
control myocytes without diamide treatment. C, Representative trace of
[Ca2+]SR measured with the sequential application of increasing diamide
concentrations. D, Percent change in steady state [Ca2+]SR with the
presence of diamide in proportion to [Ca2+]SR before diamide application.
*P<0.05 vs. control n=3 (7 myocytes total)
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Figure 7. RyR2 Oxidation and Diastolic [Ca2+]SR with N-Ethylmaleimide and Diamide

A, Representative trace of [Ca2+]SR measured in an intact ventricular myocyte
with NEM application for 1 min followed with sequential application of 10 µM
and 50 µM diamide. B, Percent change in steady state [Ca2+]SR with the
presence of diamide in proportion to [Ca2+]SR before diamide application. C,
Western immunoblot (non-reducing) against RyR2 from total lysate of isolated
myocytes subjected to diamide (50 µM) with or without pretreatment with
NEM (500 µM). n=6 (8 myocytes total)
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RyR2 Oxidative PTMs Induced by the Thiol Oxidant Diamide
Diamide has been shown previously to induce inter-subunit disulfide crosslinking of RyR1 from skeletal muscle (Aghdasi et al., 1997). Therefore, we measured
relative cross-linking of RyR2 in isolated ventricular myocytes in parallel with [Ca2+]SR
measurements. Using western blot analysis with non-reducing SDS-PAGE we quantified
the amount of monomeric RyR2 relative to total RyR. Total RyR2 was measured from
each protein sample in the presence of the reducing agent DTT (200 mM). With
increasing diamide concentrations, the level of monomeric RyR2 dissipated while crosslinked RyR2 became more pronounced (Fig. 6A). Relative cross-linking ratios were
calculated as the difference in total RyR2 and monomeric RyR2 divided by total RyR
((Total RyR2 – Monomeric RyR2) / Total RyR2). While there was no measurable crosslinking without diamide, RyR2 is nearly maximally (~90%) cross-linked in the presence of
50 µM diamide (10 µM: 20.7% ± 1.3; 25 µM: 57.2% ± 5.2; 50 µM: 87.0 ± 9.1; 100 µM:
93.0 ± 4.7; Fig. 6B). Steady state diastolic [Ca2+]SR was maximally effected by 50 µM
diamide, as shown previously, suggesting that intersubunit cross-linking of RyR2 is a
strong regulator of [Ca2+]SR.
Effect of Oxidized Glutathione SR Ca2+ leak
Increased protein glutathione mixed disulfides are a common result of oxidative stress.
Here, permeabilized myocytes were used as a different approach to investigate how
GSSG affects RyR2 and SR Ca2+ leak. Previous studies have used GSSG to induce protein-
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Figure 8. RyR2 Oxidation and SR Ca2+ Leak with GSH and GSSG

A, Representative [Ca2+]SR profiles ; 5 mM GSH (black) or 5 mM GSSG
(gray). SR Ca2+ leak was measured as the change in free [Ca2+]SR as a
function of time after the application of TG. B, Fold change of SR Ca2+ leak
rates. C, Western immunoblot (non-reducing) against RyR from total lysate
of permeabilized myocytes with the addition of GSH or GSSG (5 min).
*P<0.05 n=3 (9, 6, 7 myocytes total; Control, GSH, GSSG respectively)
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glutathione mixed disulfides in vitro and in vivo (Tang et al., 2011;Wang et al., 2005). To
date, the effect of GSSG on RyR2 has only been studied using in-vitro assays with SR
microsomes. Since GSH cannot permeate the cellular membrane, controlled
manipulation of the cellular GSH environment was achieved by introducing GSH into the
cell after rendering the cellular membrane permeable using a mild detergent (saponin).
Membrane permeabilization provides several advantages in the context of our
experiments: the cytosolic milieu is tightly controlled and cytosolic GSH and GSSG levels
can be easily manipulated. This also allows us to control for cytoplasmic ion and ATP
concentrations that can also affect RyR2 channel function. Using myocytes loaded with
Fluo-5N entrapped within the SR, either GSH (5mM) or GSSG (5mM) was introduced
immediately after sarcolemma permeabilization with saponin. SR Ca2+ leak was
estimated from the rate of [Ca2+]SR decay after the inhibition of SERCA with TG (10 μM).
With the introduction of GSSG in permeabilized myocytes (before TG), we observe a
slow decline in [Ca2+]SR as opposed to GSH where [Ca2+]SR is maintained at a steady state
(Fig. 8A). With the application of TG, GSSG significantly increased SR Ca2+ leak
approximately 3-fold relative to the basal leak rate (no glutathione), whereas GSH had
no significant effect on leak (Fig. 8B). These results suggest that RyR2 is already highly
reduced and therefore is unaffected by the addition of GSH in the cytosolic environment
of permeabilized myocytes. SR Ca2+ leak in cardiomyocytes, mediated primarily through
RyR, occurs in the form of Ca2+ sparks as well as spark-independent leak (Zima et al.,
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2010). At low diastolic [Ca2+]SR (<300 μM), SR Ca2+ leak occurs mostly in the absence of
Ca2+ sparks. Whereas at high diastolic [Ca2+]SR (>600 μM), sparks became a significant
contributor to SR Ca2+ leak. We found that GSSG increased SR Ca2+ leak to the same
degree at all measured [Ca2+]SR levels (Fig 4B), suggesting that GSSG stimulates both
spark and spark-independent Ca2+ leak.
Since diamide stimulates SR Ca2+ release and RyR2 cross-linking (Fig 5 and 6), we
investigated whether GSSG has a similar effect of the RyR2 structure in permeabilized
myocytes. Using western blot analysis with non-reducing SDS-PAGE, we found that
GSSG induces cross-linking of RyR2 (46.9 ± 12.5%; n=3). The RyR2 cross-linking was not
observed in control permeabilized myocytes (no glutathione) or after incubation of
myocytes with GSH. Moreover, pretreatment with NEM (500 µM) prevented crosslinking of RyR2 induced by GSSG (Fig. 8C). These results demonstrate that GSSG alone
can induce RyR2 inter-subunit cross-linking.
Importantly, S-glutathionylation of RyR2 itself has been shown to be associated
with increased channel activity (Bull et al., 2008). In order to determine if Sglutathionylation of RyR2 is contributing to the enhanced SR Ca 2+ leak under these
experimental conditions, permeabilized myocytes were treated with glutaredoxin (5
units/µL) and GSH (5 mM) as an attempt to reverse any S-glutathionylation induced by
acute GSSG treatment (Aracena-Parks et al., 2006). During this treatment period, there
was no significant change in the rate of decline of [Ca2+]SR (Fig. 9A,B). Next, western blot
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Figure 9. Contribution of RyR2-Glutathionylation in GSSG Induced SR Ca2+ Leak

A, Representative [Ca2+]SR profile ; 5 mM GSSG (red) 5mM GSH + 5U/µL
GRX (blue). B, Absolute rate of decline of [Ca2+]SR . n=3 (6 myocytes total)
C, Western immunoblot (non-reducing) against RyR2 and GSH (PSSG) from
total lysate of permeabilized myocytes with the addition of GSSG (5 min).
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analysis using a pan anti-GSH Ab was carried out to determine the level of RyR2 Sglutathionylation. Using this technique, there was no detectable S-glutathionylation of
RyR2 (cross-linked) as a result of GSSG treatment (Fig. 9C). These results suggest that
irreversible oxidation in the form of inter-subunit cross-linking is the major contributor
of SR Ca2+ leak under our conditions.
Effect of Oxidized Glutathione on Ca2+ Spark Frequency
In previous publications, it has been shown that increased spark-mediated Ca2+
leak occurs in the presence of oxidative stress (Yan et al., 2008;Zima et al., 2004). In
order to determine the effect of glutathione on Ca2+ sparks, we measured spark
properties in permeabilized myocytes with GSH or GSSG introduced into the cytosol
after a steady state control frequency was established (Fig. 10A). We found that GSSG
caused a significant increase in spark frequency 1 min after application. However, spark
frequency declined back to control levels after 5 min. Although not significant, spark
amplitude declined over time during the presence of GSSG (Fig. 10B). These results
suggest that increased RyR-mediated SR Ca2+ leak leads to depleted SR Ca2+ load and
therefore, decreased Ca2+ spark amplitude. Furthermore, there was no significant
difference in Ca2+ spark frequency and amplitude between control and GSH (Fig. 11).
Effect of Oxidized Glutathione on Single RyR2 Channel Activity
It has been reported previously that both GSH and GSSG affects RyR2 channel
open probability (Po). We therefore investigated the effect of GSH and GSSG on RyR2
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Figure 10. Ca2+ Spark Properties with GSSG

A, Representative confocal linescan images of cytosolic Ca2+ fluorescence
(Rhod-2) and corresponding traces of Ca2+ sparks in control and GSSG (1
and 5 min after application). B, Absolute values of spark frequency and
amplitude for both control and GSSG. Spark frequency was significantly
increased with GSSG at 1 min compared to control. *P<0.05; n=4 (7
myocytes total)
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Figure 11. Ca2+ Spark Properties with GSH

A, Representative confocal linescan images of cytosolic Ca2+ fluorescence
(Rhod-2) and corresponding traces of Ca2+ sparks in control and GSH (1
min after application). B, Absolute values of spark frequency and
amplitude for both control and GSH. n=4 (8 myocytes total)

78

Figure 12. RyR2 Single Channel Recordings with GSSG and GSH

RyR Po was measured using a lipid bilayer apparatus. A, Representative
RyR single channel recordings in the presence of either GSH or GSSG. (C –
closed and O - open state) B, RyR Po in the presence of 5 mM GSH and 5
mM GSSG. *P<0.05 ; GSH, n=4; GSSG, n=5
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activity by measuring single channel current in planar lipid bilayers (Fig. 12A). In these
experiments, SR microsomes from rabbit hearts were incorporated into the bilayer and
GSH or GSSG was introduced into the cis (cytosolic) side of the chamber. We found that
GSH decreased Po of RyR2 (from 0.083±0.019 in control to 0.039±0.010 (n=4) in the
presence of GSH), while GSSG significantly increased Po (from 0.092±0.015 in control to
0.193±0.033 (n=5) in the presence of GSSG; Fig. 12B). The effect of GSSG was measured
within 30 seconds of application and was completely reversed with the application of
DTT.
Simplified Cardiac CICR in HEK293 Cells
In order to determine the redox sensitivity of RyR2 independent of its auxiliary
proteins (making up the cardiac RyR2 complex), an alternative approach was developed
in HEK293 cells expressing recombinant RyR2 so that cardiac CICR could be mimicked in
vivo. HEK293 cells have the ability to be easily transfected with large cDNA plasmids
allowing for co-expression of both recombinant RyR2 and SERCA2a. Also, an advantage
to the HEK293 cell line is that it lacks endogenous RyR2, thereby permitting the study of
only recombinant RyR2. This approach generates SCWs, recorded using Rhod-2 Ca2+
indicator within the cellular environment, that are spatially and temporally similar to
those that occur in cardiomyocytes (Fig. 13A). This technique also makes it possible to
characterize redox sensitive residues by comparing the propensity of SCWs of RyR2wt
and RyR2 possessing cysteine mutations during oxidative stress. Ultimately,
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mutagenesis of the critical cysteines involved in RyR2 intersubunit cross-linking will
allow us to explore their functional relevance using the HEK293 cell CICR model. Of
particular interest is the cysteine at residue 3602 of RyR2, which has been shown to be
highly redox sensitive and suggested to participate in disulfide formation (Aracena-Parks
et al., 2006). Generated by Dr. Bovo, the RyR2 mutant C3602A plasmid was used in
these experiments in order to determine if intersubunit cross-linking or redox sensitivity
is affected.
Effect of Oxidants on Spontaneous Ca2+ Release in HEK293
Our initial studies determined that Ca2+ release from the ER can only be elicited if
RyR2 is coexpressed with SERCA2a in HEK293 cells. Neither the expression of RyR2 or
SERCA2a alone was sufficient to induce Ca2+ release events. Therefore, all experiments
were done in cells expressing both proteins. By perfusing HEK293 cells with Tyrode
solution at high extracellular Ca2+ (>2mM), cytosolic SCW could be elicited with the
plasma membrane intact. However, all redox studies were carried out in permeabilized
cells. This was done in order to avoid variability in [Ca2+]i as a result of changes in
plasmalemma permeability during oxidative stress. Comparable to cardiomyocytes,
Ca2+ release from the ER could be elicited with the application of caffeine at a high
concentration (10 mM). Importantly, the observed SCWs were sensitive to the
application of caffeine at a low concentration (100 μM), which is indicative of enhanced
sensitivity of RyR2 to [Ca2+]i. This characteristic behavior of RyR2 not only confirms the
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Figure 13. WT and C3602A RyR2 SCWs in HEK293 with Diamide Treatment

A, Only cells that co-expressed RyR2 and SERCA2a (HEK293 cell membrane marked by white line; Left) generate ER
Ca release. Representative SCW in HEK293 cell and ventricular myocyte (Right) B, Conserved residues of RyR1 and
RyR2 cytosolic motif; RyR1 3635 and RyR2 3602 Cysteine (yellow) C, Representative cytosolic Ca2+ fluorescence
traces from HEK293 expressing recombinant WT and C3602A RyR2 of SCW in control and diamide (100 µM). D,
Relative change in SCW propensity. *P<0.05 ; WT, n=7; C3602A, n=4
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origin of the SCW, but it also allows us to determine the activity of RyR2 by measuring
the propensity of SCW before and after treatment with oxidants.
After permeabilization, cytosolic solution containing Ca2+ was introduced into
the HEK293 cells promoting the generation of SCWs. Prior to experimentation with
oxidants, [Ca2+]i of 250 nM was determined to be the average threshold to elicit
spontaneous Ca2+ release by RyR, which was lower than what was measured previously
in cardiomyocytes. Increasing [Ca2+]i to 300 nM promoted SCWs that occurred in an
oscillatory manner and therefore, could more easily be calculated as a rate. After 5
minutes post-permeabilization, the steady state (control) SCWs were recorded for 1 min
before treatment. Figure 13B shows a representative recording of the average
fluorescence taken from the cytosolic region of an individual HEK293 cell. With the
introduction of diamide (100 μM), the relative change in the rate of SCW was
significantly increased immediately after application. Furthermore, the increased SCW
propensity was maintained for the duration of the experiment. The relative change in
amplitude of SCWs, however, was significantly decreased over time. This change seen
in Ca2+ wave properties is typical for increased RyR2 channel activity, as shown with low
dose caffeine treatment (Zima et al., 2008b). Using the identical cytosolic solution (300
nM [Ca2+]i), oscillating SCWs were elicited in permeabilized HEK293 cells expressing
RyR2 C3602A. Similar to RyR2wt, the relative change in the rate of SCW was
significantly increased, while the relative change in amplitude of SCWs was significantly
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decreased as a result of diamide treatment (Fig. 13C, D). In all untreated HEK293 cells
(no changes in oxidation), the rate and amplitude of SCWs remained unchanged
throughout the experimental time window.
Next, we examined if recombinant RyR2 expressed in HEK293 cells is susceptible
to intersubunit cross-linking. Qualitatively, both monomeric and cross-linked RyR2 was
measured using western blot analysis with non-reducing SDS-PAGE. To ensure the
cross-linking was redox dependent, RyR2 was measured from each sample in the
presence of the reducing agent DTT (200 mM). As demonstrated previously in isolated
myocytes, diamide treatment induced intersubunit cross-linking of RyR2 (Fig. 4).
Similarly, HEK293 cells treated in culture with diamide (100 μM) for 5 min induced
intersubunit cross-linking of recombinantly expressed RyR2wt. Furthermore, C3602A
RyR2 mutant presented no resistance against diamide induced intersubunit cross-linking
(Fig. 14), suggesting it is not relevant in intersubunit cross-linking or increased RyR2
activity under the experimental conditions.
Protective Effect of Nitrosyl Donor on Steady State [Ca2+]SR
A growing body of evidence has implicated NO as an important molecule that is
protective against oxidative stress. The covalent attachment of NO with a reactive free
thiol, termed S-nitrosylation, is a ubiquitous and biologically reversible PTM that has
been shown to play an important role in cardioprotection. One potential mechanism of
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Figure 14. WT and C3602A RyR2 Diamide Induced Intersubunit Cross-linking in HEK293

Western immunoblot (non-reducing) against RyR2 from total lysate of HEK293
expressing recombinant WT and C3602A RyR2 with the addition of diamide (100
µM).
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NO dependent cardioprotection is the ability for S-nitrosylation to prevent further thiol
oxidation during periods of oxidative stress.
The pharmacological agent S-Nitroso-N-acetylpenicillamine (SNAP) is commonly
used experimentally as a NO donor in intact ventricular myocytes. Furthermore, it has
been shown to significantly increase total protein S-nitrosylation within minutes of
incubation. In order to determine if S-nitrosylation of RyR2 is protects against thiol
oxidation by diamide, steady state [Ca2+]SR was measured with and without
pretreatment with SNAP (50 μM). As with the previous experiment (Fig. 6), the steady
state [Ca2+]SR was measured during the diastolic phase in field-stimulated myocytes (0.5
Hz). The relative change in diastolic [Ca2+]SR in the presence of SNAP, diamide, or SNAP +
diamide was calculated as a percentage of control [Ca2+]SR (Fig. 15A, B). While diastolic
[Ca2+]SR decreases during the application of diamide (10 μM), the pretreatment of SNAP
(3 min) resulted in a significantly less drop of [Ca2+]SR during the application of diamide.
There was no measurable change in diastolic [Ca2+]SR during SNAP treatment alone.
Further analysis comparing both treatment groups shows that treatment with SNAP
results in a significantly smaller drop in diastolic [Ca2+]SR during diamide treatment.
These results suggest that increased S-nitrosylation of RyR2 limits thiol oxidation and
subsequent SR Ca2+ leak.
Next, relative cross-linking of RyR2 was measured from isolated ventricular
myocytes treated with diamide or SNAP+diamide. Using western blot analysis with non-
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Figure 15. RyR2 Intersubunit Cross-linking and Diastolic [Ca2+]SR with SNAP and
Diamide Treatment

A, Representative traces of [Ca2+]SR measured in intact ventricular myocytes
with the sequential application of SNAP and diamide vs. diamide alone. B,
Percent change in steady state [Ca2+]SR with the presence of diamide or SNAP +
diamide in proportion to [Ca2+]SR before treatment. C, Western immunoblot
(non-reducing) against RyR2 from total lysate of isolated myocytes subjected to
diamide (50 µM) with and without pretreatment of SNAP (50 µM) D, Relative
RyR2 cross-linking (n=3). *P<0.05 n=3
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reducing SDS-PAGE, relative cross-linking was determined using the quantified
monomeric RyR2 and total RyR2 (with DTT). Consistent with previous experimental
results, untreated myocytes presented low to undetectable cross-linked RyR2. As
expected, treating myocytes with diamide (50 μM) for 5 min decreased the level of
monomeric RyR2, which yielded a near maximal cross-linking ratio. By treating
myocytes with SNAP (50 μM) for 5 min before introducing diamide, intersubunit crosslinking was significantly lower with respect to diamide treatment alone (Fig 15C, D).
Effect of Nitrosyl Donor on Spontaneous Ca2+ Release in HEK293 cells
Not unlike other oxidative species, NO has the potential to covalently modify
proteins that play a role in the regulation of RyR2. Furthermore, previous studies have
implicated S-nitrosylation of RyR2 in affecting the binding affinity of regulatory proteins
making up the RyR2 complex. In order to directly examine the effect of S-nitrosylation
on RyR2 activity, the simplified CICR HEK293 model was utilized. The ability to study the
channel activity of recombinant RyR2 void of scaffolded regulatory proteins is the major
advantage of this system. Therefore, any effect of S-nitrosylating agents on channel
activity is likely due to a direct modification of RyR2.
Using the same approach, both RyR2 and SERCA2a were coexpressed in HEK293.
For these experiments, both RyR2wt and RyR2 C3602A were expressed in parallel to
determine any differences in NO sensitivity. Oscillating SCWs were generated once the
plasma membrane was permeabilized and cytosolic solution with a [Ca 2+]i of 300 nM

88

was introduced. After 5 minutes post-permeabilization, the steady state (control) SCWs
were recorded for 1 min before treatment. Figure 16 shows a representative recording
of the average fluorescence (cytosolic Ca2+) within an individual HEK293 cell. Since
permeabilization makes RyR2 accessible to impermeable pharmacological agents, both
SNAP (50 μM) and GSNO (200 μM) could be used as nitrosyl donors. The mean
amplitude and propensity for SCWs was calculated during the presence of GSNO, SNAP,
and sequential treatment of diamide (100 μM). Analysis of the data is presented as a
relative change in the mean values calculated from control and treated for each cell (Fig.
16A,B). With the introduction of SNAP, the relative change in propensity of SCW was
decreased at the 3 min time point of treatment. Although decreased, the SCW
propensity was not significantly changed in the presence of GSNO. Furthermore, the
relative amplitude of SCWs was unaffected in cells treated with either SNAP or GSNO.
To test whether nitrosyl donors are capable of protecting RyR2 from the effects of
oxidative stress, diamide was introduced immediately following the 3 min pretreatment
period. Both the propensity and amplitude of the SCWs did not significantly change
during the 5 min of diamide treatment. Further analysis of SCW parameters in the
presence of diamide from cells pretreated with and without nitrosyl donors proved to
be significantly different. While diamide treatment with no nitrosyl donor significantly
increased SCW propensity, these results suggest that nitrosyl donors
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Figure 16. RyR2 WT and C3602A RyR2 SCWs in HEK293 with SNAP, GSNO, and Diamide Treatment

A, Representative cytosolic Ca2+ fluorescence traces from HEK293 expressing recombinant WT and C2602A RyR2 of
SCW in control, SNAP (50 µM) + diamide (100 µM), and diamide alone. B, Relative change in SCW propensity for
C2602A RyR2 with diamide, GSNO (200 µM), and GSNO + diamide. C, Relative change in SCW propensity and
amplitude for WT RyR2 with GSNO, SNAP, GSNO + diamide, and SNAP + diamide. *P<0.05; WT, n=7; C3602A, n=4
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prevent the effects of diamide by limiting further oxidation of RyR2 (e.g. Intersubunit
Cross-linking).
Since cysteine 3602 of RyR2 is a potential target for S-nitrosylation, changes in
SCW propensity in cells expressing RyR2wt and RyR2 C3602A were compared. With all
treatment groups, there was no difference in the relative change of SCW propensity.
These results suggest that cysteine residue 3602 does not play a role in oxidation
dependent changes in RyR2 activity.

Aim #2: Determine the role of RyR2 oxidation on abnormal SR Ca2+ release in I/R and HF
Ischemia-Reperfusion
Resulting from I/R, intracellular Ca2+ overload and oxidative stress are the major
mechanisms that have been implicated in cardiomyocyte death, stunning, and
arrhythmogenesis. It is generally accepted that these mechanisms are interdependent
and have the ability to influence one another through multiple signaling pathways. In
order to study isolated myocytes that have been subjected to I/R, an ex-vivo low-flow
ischemia model in Langendorff perfused rabbit hearts was established in our laboratory.
Coronary occlusion I/R models are notoriously difficult to isolate viable myocytes from
myocardium that has undergone I/R. Low-flow I/R ensures that all myocytes isolated for
biochemical and functional studies will have undergone I/R. It is imperative that low
flow ischemia was sufficient to promote arrhythmogenesis during reperfusion (at
increased oxidative stress). In order to determine if the heart exhibited these attributes,
the left ventricular pressure (LVP) and electrical activity (ECG) was monitored during
throughout the protocol. Figure 17 depicts a representative recording of the ECG and
LVP at steady state, ischemia, and reperfusion. Since the ECG electrodes were placed
across the ventricles, no P wave can be discerned on the recording. However, the QRS
complex and T wave were clearly observed so that the rate of pacemaker automaticity
and regular conduction pathway could be defined. Based on the polarity and intrinsic
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frequency of the QRS complex, ventricular ectopic beats (not originating or following the
normal conduction pathway) were recorded and analyzed qualitatively. Changes in LVP
were calculated during the ischemia and reperfusion phases relative to the average
pressure during steady state. With low-flow ischemia, the relative change in pacemaker
automaticity was markedly decreased from that of the steady state frequency. With
reperfusion, the relative heart rate was significantly increased and arrhythmias were
observed in 100% of all hearts used for single myocyte isolation and experimentation.
While the LVP was significantly decreased during ischemia, no significant difference was
observed in LVP during reperfusion compared to control steady state.
Effects of I/R on SR Ca2+ Fractional Release and Leak
In order to assess the effect of I/R on SR Ca2+ handling, RyR-mediated SR Ca2+ release
was measured in isolated myocytes from low flow I/R hearts and sham hearts. Using
the Ca2+ indicator Fluo-4AM, cytosolic Ca2+ was measured in isolated ventricular
myocytes. Similar to previous fractional release measurements, myocytes were paced
at 0.75 Hz and SR Ca2+ load was measured as the amplitude of the Ca2+ transient
induced by caffeine (10 mM) application. LTCC contribution was estimated from the
amplitude of the AP-induced Ca2+ transient during the application of caffeine. The
average SR fractional release in myocytes isolated from I/R hearts was significantly
higher than that of sham (Fig. 18A). These results indicate that RyR-mediated SR
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Figure 17. LVP and ECG During Ex-Vivo Low-Flow I/R

Representative recordings of LVP and ECG during low flow I/R A, Control full perfusion B, Low-flow ischemia C,
Reperfusion; arrhythmogenesis D, Reperfusion; tachycardia E, Intrinsic heart rate before, during, and after low-flow
ischemia F, Relative change in LVP before, during, and after low-flow ischemia. n=11

94

Ca2+ release is significantly increased as a result of I/R.
Next, the effect of I/R on RyR-mediated SR Ca2+ leak was investigated in
permeabilized myocytes. Not only is SR Ca2+ leak used as a complementary parameter
to SR fractional release, but this approach allows for a more direct measurement of
RyR2 channel activity as a result of PTMs. I/R injury can result in changes in cytoplasmic
ion concentrations and ATP concentration, which can have a profound effect RyR2
channel function. With this approach, membrane permeabilization allows us to control
for all cytoplasmic variables that may potentially be different between I/R and sham.
Using myocytes loaded with Fluo-5N entrapped within the SR, cytosolic solution
containing [Ca2+]i of 150 nM was introduced immediately after sarcolemma
permeabilization with saponin. SR Ca2+ leak was estimated from the rate of [Ca2+]SR
decay after the inhibition of SERCA with TG (10 μM). For each myocyte leak protocol,
the [Ca2+]SR decay was differentiated in order to determine SR Ca+ leak rate for a given
[Ca2+]SR. The resulting leak rates were compiled and averaged within 100 μM ([Ca2+])
increments (Table 1). Myocytes isolated from I/R hearts had a significantly increased SR
Ca2+ leak rate than that of sham myocytes (Fig. 18B).
Effects of I/R on Redox Environment and the Oxidation of RyR2
While studies have implicated oxidative stress in SR Ca2+ dysfunction, it is not yet
clear to what extent the oxidation of RyR2 plays in abnormal SR Ca2+ handling in I/R.
During oxidative stress, the redox potential can shift leading to an increase in GSSG. To
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Figure 18. SR Ca2+ Leak and Fractional Release in Sham and I/R Myocytes

A, SR Ca2+ fractional release from Sham (CNTL) and I/R myocytes. B, SR Ca2+
leak rates plotted from table 1; SHAM (Control; black) or low flow I/R (I/R; gray).
SR Ca2+ leak was measured as the change in free [Ca2+]SR as a function of time
after the application of TG.*P<0.05 Control, n=4; I/R, n=5
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Table 1. SR Ca2+ Leak Rates of I/R Myocytes

Control (Sham)
[Ca2+]SR bin
(μM)
0-100
101-200
201-300
301-400
401-500
501-600
601-700
701-800
801-900
901-1000
1001-1100

[Ca2+]SR
(Mean)
49.4
153.6
254.7
349.3
449
545.7
640.7
736.8
848.9
934.9
1029.9

Leak Rate μM/s
(Mean ± SEM)
1.66724 ± 0.20
3.40569 ± 0.24
4.78037 ± 0.58
5.19437 ± 0.84
6.09358 ± 0.80
6.94071 ± 1.45
7.98666 ± 1.03
9.09568 ± 1.83
9.61218 ± 1.42
11.54768 ± 1.39
13.20784 ± 1.84

I/R
[Ca2+]SR
(Mean)
37.6
151.6
239.9
341
447.9
524.9
662.4

Leak Rate μM/s
(Mean ± SEM)
1.2248 ± 0.15
4.93024 ± 0.75*
7.205 ± 1.37*
9.09083 ± 2.87*
9.42169 ± 1.94*
9.41593 ± 1.63
13.17702 ± 2.31*

-

-

Number of rabbit myocyte isolations used for leak measurements was
n=3. [Ca2+]SR was divided into 100 μM bins and [Ca2+]SR data was compiled
and averaged within each bin. Leak rates were analyzed as the decrease
in Ca2+ over time (μM/s).
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Figure 19. Relative RyR2 Free Thiols in I/R

A, Representative mBB and comassie gel of RyR2 from sham (CNTL), I/R, and I/R treated with DTT (5 mM; Fmax). B,
Relative RyR2 free thiols. n=3 C, GSSG/GSH ratios from fluorometric analysis. n=3 *P<0.05

98

exam the effect of low-flow I/R on the cellular redox environment, the levels of GSH and
GSSG were measured from cardiomyocytes isolated from low flow I/R hearts. Using a
fluorescent probe, GSH was measured in deproteinated lysate from ventricular tissue
biopsied before and after I/R. Analysis of GSH and Total GSH fluorescence determined
that the GSSG/GSH ratio was significantly elevated in tissue after I/R indicating that
oxidative stress was induced during reperfusion (Fig. 19C). In order to determine if
oxidation of RyR2 took place as a result of I/R, changes in relative free thiol content
were measured in isolated myocytes from sham and I/R hearts. For each isolation,
myocyte aliquots were either untreated, completely reduced with DTT (5 mM; Fmax), or
oxidized with DTDP (0.5 mM; Fmin) and then incubated with the fluorescent thiol probe
mBB. By resolving RyR2 using reducing SDS-PAGE, analysis of RyR2 free thiol content
determined that RyR2 was significantly more oxidized in myocytes isolated from I/R
hearts compared to that of sham hearts (Figure 19A,B).
Given that RyR2 was determined to be susceptible to intersubunit cross-linking,
the next approach was directed toward determining if the oxidative stress induced in
low flow I/R was sufficient to induce this modification. Using western blot analysis with
non-reducing SDS-PAGE we measured monomeric RyR2 relative to total RyR. Total RyR2
was measured from each protein sample in the presence of the reducing agent DTT (200
mM). In myocytes isolated from I/R hearts, the cross-linked form of RyR2 was
undetectable.
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Intersubunit Cross-Linking of RyR2 in Coronary Occlusion Model of I/R
Since low flow I/R may not be sufficient to induce oxidative stress at a severe
magnitude that promotes cross-linking, a coronary occlusion model was developed in
order to localize the area of ischemia and induce 100% occlusion. Using a similar
protocol to low flow I/R, hearts underwent ischemia and reperfusion for identical
periods of time. Monomeric RyR2 relative to total RyR2 was measured from isolated
tissue biopsies taken from the area of ischemia and remote myocardium. Tissue
isolated from the ischemic region had a significantly decreased level of monomeric RyR2
and an observable cross-linked form of RyR2 (Fig. 20A). Relative cross-linking ratios
were calculated as the difference in total RyR2 and monomeric RyR2 divided by total
RyR. Analysis of relative cross-linking in ischemic myocardium was calculated as 0.16 ±
0.07 (Fig. 20B). These results suggest that coronary occlusion I/R is sufficient to induce
intersubunit cross-linking of RyR2, which likely promotes abnormal SR Ca2+ handling at
the area of injury.
Cardiac Function of Failing Hearts in Rabbit Model of HF
Non-ischemic HF was induced in rabbits using a combined insult of aortic
insufficiency and constriction. Two-dimensional echocardiography was used to
determine the progression of HF at 2 to 4 week intervals after insult. The calculated
parameters for diastolic left ventricular internal dimension (LVIDd) and left ventricular
fractional shortening (LVFS) was determined prior to sacrifice and myocyte isolation
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Figure 20. RyR2 Intersubunit Cross-linking in Coronary Occlusion I/R

A, Western immunoblot (non-reducing) against RyR2 from total lysate of whole
tissue biopsies from remote and I/R myocardium B, Relative RyR2 cross-linking
*P<0.05; n=3
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Table 2. Echocardiography Parameters of Failing Rabbit Hearts
HF
Rabbit
S38
S46
S48
S55
S62
S59
S71
S65
S72

LVIDd
Initial
(cm)
1.3
1.2
1.5
1.2
1.1
1.5
1.4
1.6
1

LVIDd
Before Sac.
(cm)
1.9
1.7
2.3
2.1
1.8
2.4
2.1
2.4
1.8

Average Increase
Standard Error Of Mean

Percent
Increase
46.15%
41.67%
53.33%
75.00%
63.64%
60.00%
50.00%
50.00%
80.00%
57.75%
4.35%

LVFS
Initial
(%)
29.7
30
33.7
29
31.1
27.6
33.3
34
29.3

LVFS
Before Sac.
(%)
22
24.8
26.2
16.5
18.7
18.7
15.5
18.1
24.1

Average Decrease
Standard Error Of Mean

Total number of rabbits used in the combined studies was n=9. The left
ventricular internal diameter during diastole (LVIDd) and left ventricular
fractional shortening (LVFS) was measured prior to surgery (initial) and
before myocytes isolation (Sacrifice).

Percent
Decrease
25.93%
17.33%
22.26%
43.10%
39.87%
32.25%
53.45%
46.76%
17.75%
33.19%
4.41%
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Table 3. SR Ca2+ Leak Rates of HF Myocytes

Control (Sham)
[Ca2+]SR bin
(μM)
0-100
101-200
201-300
301-400
401-500
501-600
601-700
701-800
801-900
901-1000

[Ca2+]SR
(Mean)
42.8
147.6
247.3
349.7
456.5
554.1
642.1
754
856.2
970.2

Leak Rate μM/s
(Mean ± SEM)
1.02978 ± 0.18
1.55087 ± 0.22
2.66749 ± 0.24
3.88337 ± 0.81
4.39206 ± 0.82
5.34739 ± 0.97
7.49380 ± 1.12
9.82630 ± 1.06
12.32001 ± 1.29
16.88586 ± 1.31

HF
[Ca2+]SR
(Mean)
45.2
142.8
242.5
340.4
449.7
549.3
654.1
-

Leak Rate μM/s
(Mean ± SEM)
1.11663 ± 0.26
2.75434 ± 0.23
5.35821 ± 0.61*
7.84119 ± 1.12*
10.08685 ± 2.93*
12.49379 ± 1.13*
18.08933 ± 1.81*
-

Number of rabbit myocyte isolations used for leak measurements was
n=3. [Ca2+]SR was divided into 100 μM bins and [Ca2+]SR data was compiled
and averaged within each bin. Leak rates were analyzed as the decrease
in Ca2+ over time (μM/s).
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(Table 2). The percent change in both parameters was calculated relative to the
baseline measurements taken prior to the surgeries.
Effects of HF on SR Ca2+ Fractional Release and Leak
In order to assess the effect of HF on SR Ca2+ handling, RyR-mediated SR Ca2+
release was measured in isolated myocytes from failing hearts and sham hearts. Using
the Ca2+ indicator Fluo-4AM, cytosolic Ca2+ was measured in isolated ventricular
myocytes. Identical to the protocol for I/R, myocytes were paced at 0.75 Hz and SR Ca 2+
load was measured as the amplitude of the Ca2+ transient induced by caffeine (10 mM)
application. LTCC contribution was estimated from the amplitude of the AP-induced
Ca2+ transient during the application of caffeine. The average SR fractional release in
myocytes isolated from failing hearts was significantly higher than that of sham (Fig.
21A). These results indicate that RyR-mediated SR Ca2+ release is significantly increased
in the myocytes isolated from failing hearts.
Next, the effect of HF on RyR-mediated SR Ca2+ leak was investigated in
permeabilized myocytes. As with I/R injury, HF can affect the cytosolic milieu and
intracellular Ca+ buffering, which can have a profound effect RyR2 channel function.
Using myocytes loaded with Fluo-5N entrapped within the SR, cytosolic solution
containing [Ca2+]i of 150 nM was introduced immediately after sarcolemma
permeabilization with saponin. SR Ca2+ leak was estimated from the rate of [Ca2+]SR
decay after the inhibition of SERCA with TG (10 μM). For each myocyte leak protocol,
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Figure 21. SR Ca2+ Leak and Fractional Release in Sham and HF Myocytes

A, SR Ca2+ fractional release from Sham (CNTL) and HF myocytes. B, SR Ca2+ leak
rates plotted from table 1; SHAM (Control; black) or HF (red). SR Ca2+ leak was
measured as the change in free [Ca2+]SR as a function of time after the
application of TG. *P<0.05 Control, n=5; HF, n=4
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the [Ca2+]SR decay was differentiated in order to determine SR Ca+ leak rate for a given
[Ca2+]SR. The resulting leak rates were compiled and averaged within 100 μM ([Ca2+])
increments (Table 3). Myocytes isolated from failing hearts had a significantly increased
SR Ca2+ leak rate than that of sham myocytes (Fig. 21B).
Force Frequency Response in HF
A blunted FFR is a characteristic defect that has been implicated in impaired
contraction of the failing heart. This limitation has been attributed to abnormal activity
of Ca2+ cycling machinery, including RyR2. However, whether or not an increase in
oxidation of RyR2 can promote a blunted FFR remains unknown. Using myocytes
isolated from rabbit HF and sham, the percent FFR was investigated in myocytes loaded
with Fluo-4AM. Ca2+ transients were recorded at a pacing frequency of 0.2 Hz, followed
by 0.75 Hz. Before each recording, myocytes were given 2 minutes at each pacing
frequency so that Ca2+ cycling could reach steady state. For each line scan recording,
the average Ca2+ transient amplitude was determined for each pacing frequency.
Frequency facilitation from 0.2 to 0.75 Hz was calculated as the relative change in
amplitude. Analysis of transient amplitudes determined frequency facilitation was
significantly lower in HF compared to that of sham (Fig. 22A, B). These results indicate
that FFR is indeed blunted in the myocytes isolated from failing rabbit hearts.
In order to test the hypothesis that oxidative stress can induce a blunted FFR
phenotype, frequency facilitation was determined in healthy myocytes exposed to low
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Figure 22. Frequency Facilitation with Diamide Treatment and HF

A, Representative Ca2+ transients from control and HF myocytes at 0.2 Hz and
0.75 Hz pacing frequencies. Frequency facilitation was measured as the percent
increase in Ca2+ transient amplitude. B, Relative facilitation from 0.2 to 0.75 Hz.
n=4 C, Representative Ca2+ transients from control myocytes at 0.2 Hz and 0.75
Hz pacing frequencies with and without the treatment of diamide (10 µM). D,
Relative facilitation from 0.2 to 0.75 Hz. *P<0.05 n=3 (7 myocytes total)

107

concentration of the cysteine oxidant diamide (10 μM). Ca2+ transients were recorded
from each myocyte at both 0.2 and 0.75 Hz in two consecutive sets (Fig. 22C). The
myocytes subjected to oxidative stress were perfused with diamide during the second
set of measurements (beginning 2 minutes prior to 0.2 Hz recording). Frequency
facilitation from 0.2 to 0.75 Hz was calculated as the relative change in amplitude and
was determined for each set. Analysis of transient amplitudes found a significantly
lower relative facilitation in the presence of diamide compared to control (Fig. 22D).
Oxidation of RyR2 in HF
Previous studies have showed an increase in oxidation of RyR2 in animal models
of heart failure. In order to determine if RyR2 is more oxidized in our rabbit HF model,
changes in relative free thiol content were measured from myocytes isolated from sham
and failing hearts. For each isolation, myocyte aliquots were either untreated,
completely reduced with DTT (Fmax), or oxidized with DTDP (Fmin) and then incubated
with the fluorescent thiol probe mBB. By resolving RyR2 using reducing SDS-PAGE,
analysis of RyR2 free thiol content determined that RyR2 was significantly more oxidized
in myocytes isolated from failing hearts compared to that of sham (Fig. 23).
With the availability of human myocardium tissue samples from failing hearts
(provided by Dr. deTombe’s laboratory), the existence of intersubunit cross-linking was
investigated. Western blot analysis with non-reducing SDS-PAGE yielded evidence that
intersubunit cross-linking was indeed present in failing myocardium (Fig. 24).
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Figure 23. Relative RyR2 Free Thiols in HF

A, Representative mBB and comassie gel of RyR2 from sham (CNTL), HF, and HF
treated with DTT (5 mM; Fmax). B, Relative RyR2 free thiols. n=3 *P<0.05
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Figure 24. RyR2 Intersubunit Cross-linking in Human HF

A, Western immunoblot (non-reducing) against RyR2 from total lysate of tissue
biopsies taken from human HF. B, Western immunoblot (non-reducing) against
RyR2 from total lysate of tissue biopsies taken from both human non-failing
(NF) and HF
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This evidence provided the rationale to investigate whether or not this oxidative
modification was present in the rabbit model of non-ischemic HF. Using the isolated
myocytes from rabbit HF, monomeric RyR2 and total RyR2 was determined. However,
myocytes isolated from failing rabbit hearts exhibited no detectable form of cross-linked
RyR2.

CHAPTER VI: DISCUSSION
Evaluating External Oxidative Stress on SR Ca Release
Oxidative stress is a recurrent mechanism underlying the pathogenesis of many
disease states. Being no exception, both ischemic and nonischemic cardiovascular
disease has been associated with oxidative stress (Zweier et al., 1987;Belch et al.,
1991;Hill & Singal, 1997;Mallat et al., 1998;Vanden Hoek et al., 1996). For the initial
study, oxidative stress was evaluated in healthy isolated myocytes stressed with high βAR stimulation. β-AR stress, commonly observed in I/R injury and in the failing heart,
has been shown to promote oxidative stress. The aim of this study was to define a
relevant concentration of ROS that can be used experimentally to mimic oxidative
stress. Using fluorescence microscopy, intracellular ROS concentration was estimated to
be approximately 100 µM based on an external exposure of standardized H2O2.
Although DCF is not selective for one particular free radical, it is most sensitive to H2O2
and lipid peroxides (Roth G & Valet G, 1990;Hoffman et al., 2008). DCF has been
evaluated as a less sensitive indicator of the hydroxyl radical, a highly reactive free
radical formed via the fenton reaction, which can potentially make the calculation here
an underestimated ROS concentration.
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Intracellular GSH is arguably the first line of defense against ROS. In particular,
GSH is a highly abundant redox buffer in the heart; as a result, increased GSSG/GSH
ratio predominates in cardiovascular disease where oxidative stress is common.
Oxidative stress also promotes protein-glutathione mixed disulfides, which are
increased due to the abundance of the reducing equivalent GSH. It is well-established
that RyR2 activity can be modulated by redox-sensitive compounds. Furthermore, it has
been shown that GSSG/GSH can affect the activity of different proteins including RyR2
(Zima & Blatter, 2006). Experimentally, both physiological and chemical oxidants can
promote increased GSSG/GSH as well as protein-glutathione mixed disulfides. However,
the effect of the aforementioned oxidative changes on RyR2 oxidation, channel activity,
and SR Ca2+ release in ventricular myocytes has not been systematically explored.
SR Ca Fractional Release
The use of external ROS to induce oxidative stress is imperative to dissect the
effect of oxidative stress in abnormal SR Ca2+ handling due to the complex nature of
cardiovascular disease. By mimicking oxidative stress in healthy ventricular myocytes
with an acute application of H2O2, the results show that cytosolic Ca2+ transient
amplitudes increase within minutes of treatment (Fig. 4). Moreover, direct
measurements of SR Ca2+ using fluorescent Ca2+ dye (Fluo-5N) entrapped within the SR
determined SR Ca2+ fractional release to be markedly elevated with H2O2 treatment. SR
Ca2+ load also decreased over time suggesting that increased SR Ca2+ leak caused a shift
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in steady state Ca2+ cycling that resulted in a depletion of SR Ca2+ content. Overall, this
data suggests that oxidative stress, induced by an external physiological oxidant (H2O2),
increases RyR-mediated Ca2+ release from the SR during ECC.
Although H2O2 is a physiologically relevant oxidant, it can potentially oxidize a
number of different protein residues including the two most susceptible to oxidation,
cysteine and methionine. Furthermore, H2O2 oxidizes phospholipids, which can
potentially damage the integrity of the sarcolemma and sarcoplasmic reticulum.
Therefore, the subsequent experimental approaches were designed to more selectively
manipulate cytosolic GSSG in order to study its effect on cardiac RyR2 channel activity in
both a cellular environment and in vitro.
Since GSSG is not membrane permeable, the diazine carbonyl compound
diamide was used to oxidize intracellular GSH within intact myocytes. It has been shown
experimentally that diamide preferentially oxidizes cysteine thiol residues, particularly
GSH (forming GSSG) in comparison to other thiol containing molecules (Kosower et al.,
1972). Either directly or indirectly (via GSSG formation), diamide can promote the
formation of protein-glutathione mixed disulfides as well as protein-protein disulfides
(Brennan et al., 2004;Hansen et al., 2009). Therefore, any change in SR Ca2+ release in
the presence of diamide is likely the effect of oxidative modifications involving cysteine
residues alone (i.e. GSSG, PSSG, or PSSP). With the acute application of diamide, our
results show that cytosolic Ca2+ transient amplitudes are maintained despite a decrease
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in SR Ca2+ load (Fig. 5A). As a result, fractional SR Ca2+ release was significantly increased
in the presence of diamide. This data suggests that elevated cytosolic GSSG increases
RyR-mediated Ca2+ release from the SR during ECC. Furthermore, AP-induced Ca2+
transients during caffeine application were also augmented suggesting that LTCC activity
is increased in the presence of diamide (Fig. 5A). These results would then corroborate
a recent study by Tang et al. showing that LTCC activity is increased as a result of Sglutathionylation (Tang et al., 2011). Because changes in LTCC complicate our
measurements of RyR-mediated Ca2+ release using cytosolic Ca2+ measurements, we
measured relative changes in SR Ca2+ depletion. Our results show that in the presence of
diamide SR Ca2+ load as well as [Ca2+]SR termination level during APs is significantly
decreased, therefore causing fractional SR Ca2+ release to be increased (Fig. 1B).
Because the sensitivity of RyR2 to CICR is reduced with decreasing [Ca2+]SR (Shannon et
al., 2000b), these results suggest that RyR2 is more sensitive to [Ca2+]SR in the presence
of diamide.
Steady State SR Ca2+ and Leak
The resulting measurements of steady state diastolic [Ca2+]SR clearly demonstrate
that diamide causes a dose-dependent decrease in [Ca2+]SR and an increase of RyR2
inter-subunit cross-linking (Fig 6). There was no further decrease in diastolic [Ca2+]SR
when diamide concentration was increased from 50 to 500 µM (Fig. 6C). In parallel,
RyR2 subunits were almost entirely cross-linked in the presence of 50 µM diamide.
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Given these results, we hypothesize that RyR2 cross-linking increases diastolic SR Ca2+
release (i.e. Ca2+ leak), which cannot be compensated by SERCA, resulting in a decreased
steady state diastolic [Ca2+]SR. A decrease in diastolic [Ca2+]SR could also be explained by
inhibition of SERCA activity. However, we found that the decay rate of the AP-induced
Ca2+ transient was increased in the presence of diamide. Moreover, there was a
tendency for steady state [Ca2+]SR to increase during the application of 500 µM diamide
suggesting that SERCA activity may be enhanced. This effect may be due to the ability of
diamide to cross-link phospholamban which can subsequently relieve SERCA inhibition
(Robia et al., 2007).
Since diamide alone has the potential of directly oxidizing cysteine residues on
RyR, a more direct approach was carried out by introducing GSSG directly into the
cytosol. This was achieved by using saponin-permeabilized myocytes. Although we are
unable to measure changes in SR Ca2+ fractional release (as with intact myocytes) with
this technique, we can confidently detect changes in RyR2 activity induced by GSSG in a
tightly controlled cytosolic environment. Consistent with the effects of diamide, our
results show that GSSG significantly increases RyR-mediated SR Ca2+ leak (Fig. 8). By
analyzing Ca2+ leak at different [Ca2+]SR, we found that GSSG increases two major
components of SR Ca2+ leak: spark and non-spark- mediated Ca2+ leak (Fig. 8B). Our
data also suggests that augmentation of spark-mediated SR Ca2+ leak after acute
application of GSSG causes a decrease in SR Ca2+ load. This would explain why we
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observe a decrease in Ca2+ spark amplitude and frequency over time (Fig. 10).
Importantly, we found that GSSG within permeabilized myocytes is sufficient to induce
cross-linking of RyR2 (similar to diamide). In accordance with previous bilayer studies
(Zable et al., 1997;Feng et al., 2000), our single channel recordings reveal that GSSG
significantly increases Po of RyR2 and this effect can be restored by DTT.
Intersubunit Cross-linking of RyR2
The results of these studies reveal a novel mechanism by which GSSG can affect
RyR-mediated Ca2+ release in rabbit ventricular myocytes. We found that oxidation of
RyR2 by GSSG is associated with formation of a disulfide bond between two subunits
within the tetramer (i.e. inter-subunit cross-linking). Because the inter-subunit dynamic
within the RyR2 complex has been proposed to play an important role in channel gating
(Abramson & Salama, 1989;Orlova et al., 1996), we suggest that inter-subunit crosslinking increases RyR2 activity and SR Ca2+ leak, causing depletion of SR Ca2+ load.
Protein-glutathione mixed disulfides can occur through the interaction between
a reactive cysteine within a protein and GSH. This modification can also occur through a
thiol/disulfide exchange mechanism in which GSSG reacts directly with a free protein
thiol (Tang et al., 2011;Wang et al., 2005;Schafer & Buettner, 2001). In this study, GSSG
was used at high concentrations in order to promote thiol/disulfide exchange between
free thiols on RyR2 and GSSG. Although the concentration of GSSG is at an extreme
range, it is my belief that these findings introduce important new insights into molecular
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mechanisms of redox-modification of RyR2. The results of this study reveal a novel
mechanism by which oxidative stress can affect RyR2 activity and SR Ca2+ release in
ventricular myocytes. With oxidative stress promoting the formation of GSSG, the
subsequent oxidation of RyR2 induced the formation of a disulfide bond between two
RyR2 subunits. In control conditions, RyR2 was detected only as a single ~560 kDa band.
However, after treatment of myocytes with GSSG or diamide, RyR2 can be measured as
two separate bands: as a monomer with molecular mass of ~560 kDa and as a dimer
>1MDa. The monomeric structure of RyR2 can be restored by DTT, indicating that redox
modification of the RyR2 was involved in this effect. Although the exact mechanism that
promotes intersubunit cross-linking is unclear, it has been suggested that Sglutathionlyation acts as an intermediate for protein disulfide formation (Bass et al.,
2004;Cumming et al., 2004;Brennan et al., 2004). Furthermore, the data presented here
suggest that mixed disulfide formation between RyR2 and GSH during oxidative stress
may facilitate RyR2 inter-subunit cross-linking leading to increased RyR2 activity. It is
important to note that S-glutathionylation of RyR2 itself has been shown to be
associated with increased channel activity (Bull et al., 2008). The attempt to
enzymatically reverse S-glutathionylation of RyR2 potentially induced by the acute
application of GSSG showed no change in the rate of decline of [Ca2+]SR (Fig. 9).
Furthermore, western blot analysis using a pan anti-GSH Ab could not detect RyR2 Sglutathionylation. It is possible that this technique is not sensitive enough to detect
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small changes in S-glutathionylation of RyR2. Altogether, the results suggest that
irreversible oxidation in the form of inter-subunit cross-linking is the major contributor
of SR Ca2+ leak under our conditions.
Both intra- and inter-subunit interactions have been proposed to play an
important role in RyR2 channel gating (Zissimopoulos & Lai, 2007). Therefore, intra- or
inter-subunit cross-linking as a result of oxidative stress would potentially affect RyR2
channel activity. Although we cannot rule out intra-subunit cross-linking in our
experiments, our results suggest that RyR2 inter-subunit cross-linking plays an
important role in increasing cardiac RyR2 activity and augmentation of diastolic SR Ca 2+
leak. It was first suggested by Abramson and Salama that disulfide formation between
subunits is involved in the channel opening of skeletal RyR1 (Abramson & Salama, 1989).
It has recently been shown by Zissimopoulos and colleagues that the cardiac isoform of
RyR2 forms an inter-subunit disulfide between N-terminal domains under ambient
conditions. However, their studies suggest that N-terminal inter-subunit cross-linking
plays an important role in cardiac RyR2 tetramer assembly as well as mediating channel
closure. Furthermore, they show that disrupting the inter-subunit interaction between
N-terminal domains of RyR2 subunits can promote channel opening (Zissimopoulos et
al., 2013). In our experiments, however, cardiac RyR2 inter-subunit cross-linking was
not measurable in control conditions suggesting that it is not likely present in the
healthy heart. Based on our results, we hypothesize that inter-subunit cross-linking of
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RyR2 as a result of oxidative stress promotes abnormal inter-subunit interactions that
facilitate channel opening and increased diastolic Ca2+ leak.
Simplifying RYR2 CICR during Oxidative Stress
A major limitation to studying the oxidation of RyR2 in cardiomyocytes is the
inability to distinguish a direct effect of the channel itself as opposed to an indirect
effect by regulatory proteins. The auxiliary proteins that make up the RyR2 complex are
likely affected by changes in redox. In order to determine the effects of channel
oxidation on SR Ca2+ release, RyR2 must be expressed in a non-cardiac system where
any activity from regulatory proteins is considered nominal. In these studies, the
HEK293 cell line was used as an expression system for both recombinant RyR2 and
SERCA2a. In addition, all experiments were carried out after permeabilization of the
plasma membrane so that the intracellular milieu could be tightly controlled. The
results from these studies clearly show that SCWs in HEK293 are sensitive to
intracellular Ca2+ as well as caffeine, which is highly characteristic of RyR2. Ultimately,
this approach allows for a strong argument to be made for the relevance of oxidative
PTMs of RyR2 on SR Ca2+ release.
Given the previously acquired results from isolated myocytes, RyR2 intersubunit
cross-linking was investigated in the HEK293 expression system. Although recombinant
RyR2 formed a functional channel in HEK293, it was not known if the cysteine residues
involved in intersubunit cross-linking were accessible to one another. Here, the results
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clearly show that diamide induces the same cross-linking effect in recombinantly
expressed RyR2 compared to those endogenously expressed in myocytes. These results
suggest that the intersubunit folding motifs and domain interactions are likely preserved
in recombinantly expressed RyR2. Furthermore, the data suggest that RyR2 intersubunit
cross-linking does not require any auxiliary proteins. The functional results corroborate
those from ventricular myocytes in that diamide induced cross-linking of RyR2 facilitates
Ca2+ release from the ER in HEK293. This is evident with the increased SCW propensity
as well as the decreased SCW amplitude over time. Similar to the spark measurements
in myocytes, spark amplitude had a tendency to decrease over time in the presence of
GSSG. This suggest that the depletion of [Ca2+]SR due to enhanced leak, not
compensated by Ca2+ reuptake, causes a subsequent decrease in trans-SR Ca2+ driving
force.
The mutagenesis of the cysteine at residue 3602, which has been suggested to
be involved in intersubunit cross-linking, did not prove to prevent diamide induced
intersubunit cross-linking. Moreover, it did not prevent or mitigate the effect of
diamide on SCWs. Even though cysteine 3602 has been shown to undergo oxidative
PTMs, the results from these studies suggest its oxidation state holds no bearing on the
effects seen with diamide.
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Protective Implications of S-Nitrosylation in Oxidative Stress
S-nitrosylation has been implicated as an important oxidative PTM that
promotes ischemic preconditioning. Targets of S-nitrosylation include proteins that are
involved in mitochondrial metabolism, apoptosis, ROS defense, protein trafficking,
myofilament contraction, and Ca2+ handling. Although it has been suggested that Snitrosylation can prevent irreversible oxidation of cysteine residues, the ability of Snitrosylation to prevent intersubunit cross-linking of RyR2 or increased SR Ca2+ leak was
not yet investigated. By pretreating myocytes with the NO donor SNAP before the
application of diamide, the steady state [Ca2+]SR is maintained at a higher level
compared to that of diamide alone. Although the SNAP concentrations used did not
completely prevent a drop in [Ca2+]SR, SNAP only partially prevented intersubunit crosslinking induced by diamide. These results suggest that S-nitrosylation, like NEM,
prevents intersubunit cross-linking and the subsequent drop in [Ca2+]SR. A major
difference between SNAP and NEM is that S-nitrosylation is readily reversible whereas Salkylation in irreversible. Therefore, SNAP likely promotes a weaker protective effect
against further oxidation than that of NEM.
In the HEK293 studies, SNAP pretreatment proved to prevent the increase in
SCW propensity as well as the decrease in SCW amplitude seen with diamide
application. These results corroborate with the steady state [Ca 2+]SR studies done in
myocytes, which provides more evidence of the protective effect of S-nitrosylation
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against detrimental Ca2+ leak induced by oxidative stress. Previous publications have
implicated deficient S-nitrosylation in abnormal SR Ca2+ handling (Gonzalez et al., 2010).
Therefore, S-nitrosylation of RyR2 is likely an essential PTM to protect against oxidative
stress and subsequent SR Ca2+ leak. By maintaining SR Ca2+ load and preventing [Ca2+]i
overload, I propose that S-nitrosylation plays a very important role in cardiac function
during periods of oxidative stress.
Oxidative Stress in Ischemia-Reperfusion Injury and Heart Failure
The magnitude of oxidative stress in cardiovascular disease has a large bearing
on the overall welfare of myocardium. It is well established that severe oxidative stress
is a major stimuli that leads to necrosis (Ryter et al., 2007;Hanus et al., 2013).
Furthermore, [Ca2+]i overload and subsequent mitochondrial Ca2+ overload will in turn
activate necrotic signaling pathways as well as promote the opening of the
mitochondrial permeability transition pore; the latter causing mitochondrial rupture and
subsequent cell death (Halestrap et al., 2004). Since intersubunit cross-linking of RyR2
induces a severe form of SR Ca2+ leak, it is likely that this oxidative PTM has a role in
promoting [Ca2+]i overload and necrosis. Also, intersubunit cross-linking of RyR2 likely
sets the stage for triggered activity and the genesis of ectopic foci.
The presented studies provide evidence for RyR2 intersubunit cross-linking in I/R
and HF. However, these results were only observable in whole tissue isolations. While
RyR2 intersubunit cross-linking was undetectable in isolated myocytes from I/R or HF,
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increased oxidation of RyR2 was evident. Furthermore, I/R and HF myocytes exhibited
increased SR Ca2+ fractional release and leak with no detectable RyR2 intersubunit crosslinking suggesting other PTMs are likely responsible. These results suggest that isolated
myocytes (intact and viable after enzymatic separation) from I/R and failing hearts have
survived due to the fact that they have not undergone the degree of oxidative stress
capable of inducing RyR2 intersubunit cross-linking.

CHAPTER VII: CONCLUSION

In conclusion, the data presented suggests that protein-glutathione mixed
disulfides play an important role in facilitating abnormal Ca2+ cycling during oxidative
stress in the heart. In this study, we introduce a new mechanism for increased RyRmediated Ca2+ leak from the SR: Oxidative stress promotes an increase in overall
glutathione mixed disulfides in turn facilitating intermolecular cross-linking of RyR2
subunits and a subsequent increase in channel activity that promotes SR Ca2+ leak and
fractional release. The data presented in this study implicates intersubunit cross-linking
as an important mechanism for the regulation of RyR2 channel activity and steady state
[Ca2+]SR. Preventing RyR2 intersubunit cross-linking has the potential to act as a
beneficial therapy in the treatment of I/R injury and HF.
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